Genetics versus environment in the pathophysiology of sagittal synostosis
Open accessAbstract
Purpose: This systematic review aims to provide an updated overview of the relative contribution of germline genetic and environmental factors to the pathophysiology of sagittal craniosynostosis (sCS). Methods: Using the PubMed database in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, relevant studies addressing genetic and/or environmental determinants of sCS in paediatric patients were systematically reviewed. Results: A total of 1238 records were identified, of which 97 studies met inclusion criteria after full-text review. Overall, 25,877 patients were included, with 11,086 diagnosed with sCS (42.8%). Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients, accounting for 12.6% of genetically tested individuals with sCS. Identified variants were distributed across 125 genes, with recurrent findings in 25 genes. Environmental and perinatal factors were more consistently reported across large population-based and case-control studies. Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies. Conclusion: Identifiable germline genetic causes appear to account for only a minority of sCS cases, whereas epidemiological evidence suggests that environmental and perinatal influences may also contribute to disease pathogenesis. Nevertheless, most cases lack identifiable germline mutations in key signalling pathways, and the available evidence does not support either genetic or environmental factors as individually deterministic drivers of disease development. Overall, the evidence synthesized in this review supports a multifactorial model for sCS, in which rare genetic susceptibility and non-genetic influences likely interact in the etiopathogenesis of the condition rather than reflecting a single dominant aetiology. However, heterogeneity across studies, differences in genetic testing methodologies, potential bias in exposure assessment, and the limited availability of integrative analyses restrict definitive conclusions regarding the relative contribution of these factors.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review of 97 studies and 11,086 sagittal craniosynostosis (sCS) patients found identifiable germline variants in only 12.6% of genetically tested sCS cases, while environmental and perinatal factors were more consistently reported. The evidence supports a multifactorial model rather than a single dominant genetic or environmental cause.
Key findings
- Among 97 included studies covering 25,877 patients, 11,086 had sCS (42.8%). Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients, accounting for 12.6% of genetically tested individuals with sCS; variants were distributed across 125 genes, with recurrent findings in 25 genes.
- Environmental and perinatal factors were more consistently reported in large population-based and case-control studies, including male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.
- Male predominance was marked (sum of studies: 5156 male and 1800 female), with odds ratios ranging from 1.46 to 4.5 (geometric mean ~2.7). Advanced maternal age (>35 years) was associated with OR 2.01–2.32; maternal smoking with OR 1.48–5.12; maternal thyroid disease with OR 1.3–2.11.
- The authors conclude that most cases lack identifiable germline mutations in key signalling pathways and that the evidence supports a multifactorial model in which rare genetic susceptibility and non-genetic influences likely interact.
Methods
- Systematic review conducted according to PRISMA guidelines using the PubMed database; the search was conducted on 31/12/2025 and identified 1238 records, of which 97 studies met inclusion criteria after full-text review.
- Included non-randomized observational studies (cohort, case-control, population-based, case series, and case reports); no randomized controlled trials were identified. Quality was assessed with AMSTAR 2 and the Newcastle-Ottawa Scale, with case reports/series narratively assessed.
- Data were extracted independently by two reviewers; because of clinical and methodological heterogeneity, a narrative synthesis was performed rather than a quantitative meta-analysis, with effect sizes and odds ratios reported where provided by original studies.
Limitations
- The paper states that heterogeneity across studies, differences in genetic testing methodologies, potential bias in exposure assessment, and limited availability of integrative analyses restrict definitive conclusions about the relative contribution of genetic versus environmental factors.
- The paper states that many studies were underpowered (only 29 of 96 cohorts included more than 200 participants), that reliance on parental self-report introduces recall bias, and that limiting the search to PubMed may have missed relevant publications.
- Evident from the text: the included evidence spans heterogeneous designs and risk levels (case reports, cohort studies, GWAS, population-based studies), and the reported genetic diagnostic yield should be interpreted cautiously because of methodological heterogeneity; the text also reports germline variants in 251 patients in the abstract but 259 patients in the Results, indicating an internal inconsistency.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
70 of 132 cited sources checked · 26 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Environmental influences, including in utero mechanical constraints, maternal health conditions, medication exposure, and other prenatal risk factors, have been proposed as contributing factors particularly in non-syndromic cases.
“Environmental influences have also been proposed as contributing factors, particularly in non-syndromic cases. These include in utero mechanical constraints, maternal health conditions, medication exposure, and other prenatal risk factors [1, 2, 11, 22–25].”
Quote in the paperNot a substantial claim3 of 7 sources checked- cites [1] Lattanzi W, Barba M, Di Pietro L, Boyadjiev SA (2017) Genetic advances in craniosynostosis. Am J Med Genet A 173:1406–1429. https://doi.org/10.1002/ajmg.a.38159 source
The Introduction (page unavailable) discusses proposed risk factors for nonsyndromic craniosynostosis, including intrauterine head constraint, maternal age, prenatal smoking, and medication exposures. It does not identify maternal health conditions as a risk-factor category for nonsyndromic cases; it also describes the evidence for several environmental exposures as mixed or inconclusive. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [2] Boulet SL, Rasmussen SA, Honein MA (2008) A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 146:984–991. https://doi.org/10.1002/ajmg.a.32208 source
- cites [11] Kajdic N, Spazzapan P, Velnar T (2018) Craniosynostosis - recognition, clinical characteristics, and treatment. Bosn J Basic Med Sci 18:110–116. https://doi.org/10.17305/bjbms.2017.2083 source
The CRANIOSYNOSTOSIS section (p. 1) identifies intrauterine constraint, maternal smoking, prenatal teratogen exposure, and antiepileptic drugs as possible predisposing factors. It discusses these factors for craniosynostosis generally, however, and does not say they contribute particularly to non-syndromic cases. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [22] Twigg SRF, Wilkie AOM (2015) A genetic-pathophysiological framework for craniosynostosis. Am J Hum Genet 97:359–377. https://doi.org/10.1016/j.ajhg.2015.07.006 source
- cites [23] Anderson PJ, Netherway DJ, McGlaughlin K, David DJ (2007) Intracranial volume measurement of sagittal craniosynostosis. J Clin Neurosci 14:455–458. https://doi.org/10.1016/j.jocn.2006.07.001 source
- cites [24] Tamburrini G, Caldarelli M, Massimi L et al (2005) Intracranial pressure monitoring in children with single suture and complex craniosynostosis: a review. Childs Nerv Syst 21:913–921. https://doi.org/10.1007/s00381-004-1117-x source
- cites [25] Clarke CM, Fok VT, Gustafson JA et al (2018) Single suture craniosynostosis: identification of rare variants in genes associated with syndromic forms. Am J Med Genet A 176:290–300. https://doi.org/10.1002/ajmg.a.38540 source
The Discussion (page unavailable) suggests that gene–environment interactions may help explain incomplete penetrance in single-suture craniosynostosis, supporting a possible environmental contribution. It does not identify in utero mechanical constraints, maternal health conditions, medication exposure, or other prenatal risk factors as contributors. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Interpretationcitation
The penetrance of SMAD6 variants appears to be modified by common regulatory variation near BMP2.
“Strong evidence supports a role for the BMP/SMAD pathway, particularly through SMAD6, whose variants represent one of the most consistent findings in midline NCS [62]; importantly, their penetrance appears to be modified by common regulatory variation near BMP2, supporting a two-locus model rather than a simple monogenic one [76].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [76] Justice CM, Yagnik G, Kim Y et al (2012) A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 44:1360–1364. https://doi.org/10.1038/ng.2463 source
The paper reports common variants associated with sagittal craniosynostosis near BMP2 and predicts a regulatory element in that region (association findings and discussion; page unavailable). It does not report SMAD6 variants or show that BMP2-region variation modifies their penetrance. Its discussion treats gene–gene interactions as a possibility, not an established two-locus model. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Interpretationcitation
Strong evidence supports a role for the BMP/SMAD pathway in sCS, particularly through SMAD6.
“Strong evidence supports a role for the BMP/SMAD pathway, particularly through SMAD6, whose variants represent one of the most consistent findings in midline NCS [62]; importantly, their penetrance appears to be modified by common regulatory variation near BMP2, supporting a two-locus model rather than a simple monogenic one [76].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [62] Di Rocco F, Rossi M, Verlut I et al (2023) Clinical interest of molecular study in cases of isolated midline craniosynostosis. Eur J Hum Genet 31, 621–628 (2023). https://doi.org/10.1038/s41431-023-01295-y source
The Discussion reports SMAD6 variants in 7 of 43 children with isolated trigonocephaly and concludes that SMAD6 has a major role in metopic nonsyndromic craniosynostosis. That supports the SMAD6 portion of the claim, but our copy does not establish a broader role for the BMP/SMAD pathway. The later two-locus statement is attached to a different citation and is not judged here. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Findingcitation
SMAD6 variants represent one of the most consistent findings in midline NCS.
“Strong evidence supports a role for the BMP/SMAD pathway, particularly through SMAD6, whose variants represent one of the most consistent findings in midline NCS [62]; importantly, their penetrance appears to be modified by common regulatory variation near BMP2, supporting a two-locus model rather than a simple monogenic one [76].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [62] Di Rocco F, Rossi M, Verlut I et al (2023) Clinical interest of molecular study in cases of isolated midline craniosynostosis. Eur J Hum Genet 31, 621–628 (2023). https://doi.org/10.1038/s41431-023-01295-y source
- Interpretationcitation
Altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants.
“Tandem duplications of upstream IHH enhancers, rare chromosomal microdeletions and microduplications, and CNVs involving regions that include genes such as FGF2, SPRY1, SEMA5A, FBLN2, and TMEM43 support the concept that altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants [64, 85, 87, 115, 124].”
Quote in the paperSubstantial claim2 of 5 sources checked- cites [64] Fernández-Jaén A, Fernández-Perrone AL, Fernández-Mayoralas DM et al (2014) Craniosynostosis, psychomotor retardation, and facial dysmorphic features in a Spanish patient with a 4q27q28.3 deletion. Childs Nerv Syst 30:2157–2161. https://doi.org/10.1007/s00381-014-2474-8 source
- cites [85] Maldžienė Ž, Bulanovaitė E, Aleksiūnienė B et al (2019) 16p13.11-p12.3 Microdeletion identified in a patient with sagittal craniosynostosis and developmental delay. Clin Dysmorphol 28:195–197. https://doi.org/10.1097/MCD.0000000000000285 source
- cites [87] Mefford HC, Shafer N, Antonacci F et al (2010) Copy number variation analysis in single-suture craniosynostosis: multiple rare variants including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet A 152:2203–2210. https://doi.org/10.1002/ajmg.a.33557 source
The Discussion (page not provided) proposes that changes in gene dosage, including RUNX2 duplication, increase susceptibility to premature suture fusion. The Results table also identifies rare CNVs involving SEMA5A, FBLN2, and TMEM43 in people with single-suture craniosynostosis. The paper does not establish disrupted regulation or show that the affected individuals lacked pathogenic coding variants. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [115] Wentz E, Vujic M, Kärrstedt EL et al (2014) A case report of two male siblings with autism and duplication of Xq13-q21, a region including three genes predisposing for autism. Eur Child Adolesc Psychiatry 23:329–336. https://doi.org/10.1007/s00787-013-0455-1 source
- cites [124] Yu D, Li S, Liu Q, Zhang K (2017) Novel chromosomal microduplications associated with dolichocephaly craniosynostosis: a case report. Medicine (Baltimore) 96:e8729. https://doi.org/10.1097/MD.0000000000008729 source
- Findingcitation
In PHEX-related X-linked hypophosphatemic rickets (XLHR), sagittal suture involvement appears strikingly frequent and, in some cohorts, nearly constant.
“This is particularly evident in PHEX-related X-linked hypophosphatemic rickets (XLHR), in which sagittal suture involvement appears strikingly frequent and, in some cohorts, nearly constant [43, 81, 95].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [43] Arenas MA, Jaimovich S, Perez Garrido N et al (2021) Hereditary hypophosphatemic rickets and craniosynostosis. J Pediatr Endocrinol Metab 34:1105–1113. https://doi.org/10.1515/jpem-2021-0042 source
- cites [81] Lee KS, Lee BL (2019) The first Korean case report with scaphocephaly as the initial sign of X-linked hypophosphatemic rickets. Childs Nerv Syst 35:1045–1049. https://doi.org/10.1007/s00381-018-04042-7 source
- cites [95] Rothenbuhler A, Fadel N, Debza Y et al (2019) High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR). J Bone Miner Res 34:490–496. https://doi.org/10.1002/jbmr.3614 source
The Results (Craniosynostosis; page unavailable) report sagittal suture fusion in 26 of 44 children with XLHR (59%), supporting that it is strikingly frequent. The sagittal suture was involved in every child *with craniosynostosis*, but the paper does not show nearly constant involvement across an entire XLHR cohort. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Findingcitation
Variants in genes such as FGFR2, TCF12, ERF, KAT6B, ACTB, SH3PXD2B, SALL1, IFT140, SON, CASK, FOXP2, EXTL3, and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevelopmental, or systemic disorders.
“More broadly, variants in genes such as FGFR2, TCF12, ERF, KAT6B, ACTB, SH3PXD2B, SALL1, IFT140, SON, CASK, FOXP2, EXTL3, and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevelopmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Quote in the paperSubstantial claim6 of 10 sources checked- cites [41] Alghamdi M, Alhumsi TR, Altweijri I et al (2021) Clinical and genetic characterization of craniosynostosis in Saudi Arabia. Front Pediatr 9:582816. https://doi.org/10.3389/fped.2021.582816 source
The Discussion (page not provided) links FGFR2, ERF, and TCF12 to syndromic craniosynostosis, and the Results: Molecular Analysis report FGFR2 variants in six patients with characteristic facial, hand, or foot findings. Our copy does not substantiate the claim for the other listed genes or establish how often variants across that full list occur in patients with the stated additional disorders. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [47] Bashir RA, Dixit A, Goedhart C et al (2017) Lin-Gettig syndrome: craniosynostosis expands the spectrum of the KAT6B related disorders. Am J Med Genet A 173:2596–2604. https://doi.org/10.1002/ajmg.a.38355 source
- cites [48] Baumann M, Beaver EM, Palomares-Bralo M et al (2020) Further delineation of putative ACTB loss-of-function variants: a 4-patient series. Hum Mutat 41:753–758. https://doi.org/10.1002/humu.23970 source
- cites [49] Bendon CL, Fenwick AL, Hurst JA et al (2012) Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure. BMC Med Genet 13:104. https://doi.org/10.1186/1471-2350-13-104 source
- cites [78] Körberg I, Nowinski D, Bondeson ML et al (2020) A progressive and complex clinical course in two family members with ERF-related craniosynostosis: a case report. BMC Med Genet 21:90. https://doi.org/10.1186/s12881-020-01015-z source
- cites [84] Lugli L, Rossi C, Ceccarelli PL et al (2022) Townes-Brocks syndrome with craniosynostosis in two siblings. Eur J Med Genet 65:104642. https://doi.org/10.1016/j.ejmg.2022.104642 source
- cites [86] McGillivray G, Savarirayan R, Cox TC et al (2005) Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain. J Med Genet 42:656–662. https://doi.org/10.1136/jmg.2004.027888 source
- cites [90] Ohishi A, Nishimura G, Kato F et al (2017) Mutation analysis of FGFR1-3 in 11 Japanese patients with syndromic craniosynostoses. Am J Med Genet A 173:157–162. https://doi.org/10.1002/ajmg.a.37992 source
- cites [100] Sharma VP, Wall SA, Lord H et al (2012) Atypical Crouzon syndrome with a novel Cys62Arg mutation in FGFR2 presenting with sagittal synostosis. Cleft Palate Craniofac J 49:373–377. https://doi.org/10.1597/11-185 source
- cites [101] Sharova M, Markova T, Sumina M, et al (2023) Rare IFT140-associated phenotype of cranioectodermal dysplasia and features of diagnostic journey in patients with suspected ciliopathies. Genes (Basel) 14:. https://doi.org/10.3390/genes14081553 source
- Interpretationcitation
A two-locus model rather than a simple monogenic model is supported for SMAD6/BMP2 in sCS.
“Strong evidence supports a role for the BMP/SMAD pathway, particularly through SMAD6, whose variants represent one of the most consistent findings in midline NCS [62]; importantly, their penetrance appears to be modified by common regulatory variation near BMP2, supporting a two-locus model rather than a simple monogenic one [76].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [76] Justice CM, Yagnik G, Kim Y et al (2012) A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 44:1360–1364. https://doi.org/10.1038/ng.2463 source
The paper reports an association between variation near BMP2 and sagittal craniosynostosis and says the lack of Mendelian segregation suggests complex inheritance (Abstract; page unavailable). It does not establish that BMP2 variation modifies the penetrance of SMAD6 variants or support the specific SMAD6/BMP2 two-locus model; its tested gene–gene interactions were not significant after correction (Abstract; page unavailable). (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingcitation
Young maternal age has a protective effect for sCS, with OR 0.6.
“Firstly, advanced maternal age (> 35 years) has been found to highly correlate with sagittal suture fusion, with an OR ranging from 2.01 to 2.32 [2, 82, 93, 102], while young maternal age has a protective effect OR 0.6 [56].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
The Results (page not provided) associate younger maternal age (<25 versus 25–29 years) with lower odds of craniosynostosis, but report an OR of 0.7, not 0.6. The study reports an association rather than establishing a protective causal effect. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Findingcitation
The majority of studies reported an odds ratio of male occurring CS ranging from 1.46 to 4.5, with a geometric mean of ~2.7.
“The majority of the studies studied the odds ratio of male occurring CS with an OR ranging from 1.46 to 4.5 (with geometric mean of ~ 2.7) [2, 3, 15, 26, 50, 53, 74, 80, 82, 86, 96–98, 102, 103, 117].”
Quote in the paperNot a substantial claim2 of 10 sources checked- cites [2] Boulet SL, Rasmussen SA, Honein MA (2008) A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 146:984–991. https://doi.org/10.1002/ajmg.a.32208 source
- cites [3] Lajeunie E, Le Merrer M, Bonaïti-Pellie C et al (1996) Genetic study of scaphocephaly. Am J Med Genet 62:282–285. https://doi.org/10.1002/(SICI)1096-8628(19960329)62:3%3C282::AID-AJMG15%3E3.0.CO;2-G source
- cites [15] Källén K (1999) Maternal smoking and craniosynostosis. Teratology 60:146–150. https://doi.org/10.1002/(sici)1096-9926(199909)60:3%3C146::aid-tera10%3E3.3.co;2-v source
- cites [26] Zeiger JS, Beaty TH, Hetmanski JB et al (2002) Genetic and environmental risk factors for sagittal craniosynostosis. J Craniofac Surg 13:602–606. https://doi.org/10.1097/00001665-200209000-00002 source
- cites [50] Bessenyei B, Nagy A, Szakszon K et al (2015) Clinical and genetic characteristics of craniosynostosis in Hungary. Am J Med Genet A 167:2985–2991. https://doi.org/10.1002/ajmg.a.37298 source
- cites [53] Butzelaar L, Breugem CC, Hanlo P, Mink van der Molen AB (2009) Is isolated sagittal synostosis an isolated condition? J Craniofac Surg 20:399–401. https://doi.org/10.1097/SCS.0b013e31819b971a source
- cites [74] Junaid M, Slack-Smith L, Wong K et al (2023) Epidemiology of hospital admissions for craniosynostosis in Australia: a population-based study. Cleft Palate Craniofac J 60:569–576. https://doi.org/10.1177/10556656221074215 source
- cites [80] Lapehn S, Gustafson JA, Timms AE, et al (2023) Transcriptomic signatures of single-suture craniosynostosis phenotypes. Int J Mol Sci 24:. https://doi.org/10.3390/ijms24065353 source
The Introduction (section 1; page unavailable) reports nearly fourfold higher incidence among males for sagittal and metopic single-suture craniosynostosis, supporting a sex difference for those phenotypes. It does not report odds ratios across the majority of studies, a range of 1.46–4.5, or a geometric mean of about 2.7. It also notes that coronal cases are slightly more frequent among females. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [82] Lee HQ, Hutson JM, Wray AC et al (2012) Changing epidemiology of nonsyndromic craniosynostosis and revisiting the risk factors. J Craniofac Surg 23:1245–1251. https://doi.org/10.1097/SCS.0b013e318252d893 source
- cites [86] McGillivray G, Savarirayan R, Cox TC et al (2005) Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain. J Med Genet 42:656–662. https://doi.org/10.1136/jmg.2004.027888 source
The introductory passage labelled Abstract (page unavailable) says sagittal synostosis shows a male predominance. It gives no male odds ratio, range of 1.46–4.5, or geometric mean of approximately 2.7, and its statement concerns sagittal synostosis rather than craniosynostosis generally. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Premisecitation
Race and ethnicity have been reported as modifiers of sagittal craniosynostosis (sCS) risk.
“In addition, race and ethnicity have also been reported as modifiers of sCS risk. Several studies consistently report a higher prevalence among individuals of white race [29, 93], whereas lower risks have been observed in black (OR = 0.2), Hispanic (OR = 0.4), and other racial or ethnic groups (OR = 0.6) [56, 96].”
Quote in the paperNot a substantial claim4 of 4 sources checked- cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
The Results report that mothers of craniosynostosis cases were more likely than control mothers to be non-Hispanic white (74% versus 60%), and the Discussion notes a non-Hispanic white predominance among cases. These findings concern craniosynostosis across suture types; the passages do not establish race or ethnicity as modifiers of sagittal craniosynostosis risk specifically or report the quoted odds ratios for other groups. Page numbers were not available in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [93] Rasmussen SA, Yazdy MM, Carmichael SL et al (2007) Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 110:369–377. https://doi.org/10.1097/01.AOG.0000270157.88896.76 source
The Results (page unavailable) report that mothers of infants with craniosynostosis were more likely than control mothers to be non-Hispanic white. This supports a racial or ethnic difference for craniosynostosis overall, but the paper does not report that difference specifically for sagittal craniosynostosis or give the quoted race-specific odds ratios. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
- cites [96] Schraw JM, Woodhouse JP, Langlois PH et al (2021) Risk factors and time trends for isolated craniosynostosis. Birth Defects Res 113:43–54. https://doi.org/10.1002/bdr2.1824 source
- Interpretationcitation
Maternal occupation can increase exposure of metals and polycyclic aromatic hydrocarbons (PAHs) to the foetus.
“Another important factor that can influence skull growth and correct bone differentiation is maternal occupation, which can increase the exposure of metals [114, 118] and polycyclic aromatic hydrocarbons (PAHs) to the foetus [89].”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [114] Weng Z, Xu C, Chen X et al (2024) Sp1-activated FGFR2 is involved in early-life exposure to nickel-induced craniosynostosis by regulating the ERK1/2 signaling pathway. Environ Int 184:108477. https://doi.org/10.1016/j.envint.2024.108477 source
- cites [118] Xu J, Yan Q, Song C et al (2021) An Axin2 mutation and perinatal risk factors contribute to sagittal craniosynostosis: evidence from a Chinese female monochorionic diamniotic twin family. Hereditas 158:20. https://doi.org/10.1186/s41065-021-00182-0 source
The citation [89] is attached to the claim about fetal exposure to PAHs, not the separately cited claim about metals. The Discussion identifies breech presentation and intrauterine growth restriction as environmental insults, but our copy does not address maternal occupation or PAH exposure (searched: polycyclic aromatic hydrocarbons, PAHs, maternal occupation, occupational exposure). (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [89] O’Brien JL, Langlois PH, Lawson CC et al (2016) Maternal occupational exposure to polycyclic aromatic hydrocarbons and craniosynostosis among offspring in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 106:55–60. https://doi.org/10.1002/bdra.23389 source
- Findingcitation
Maternal alcohol consumption is associated with odds ratios close to unity (OR ~0.8-1.0) for sCS.
“Maternal alcohol consumption has been associated with odds ratios close to unity (OR ~ 0.8–1.0) for sCS [56, 65], but this does not imply a protective effect and does not modify existing recommendations to abstain from alcohol during pregnancy.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
- cites [65] Fisher SC, Romitti PA, Tracy M et al (2024) Associations between maternal periconceptional alcohol consumption and risk of craniosynostosis among offspring, national birth defects prevention study, 1997–2011. Birth Defects Res 116:e2420. https://doi.org/10.1002/bdr2.2420 source
- Findingcitation
Very low birth weight <2500 g is correlated with sCS, with OR=1.5-2.32.
“At birth, there are some phenotypes that has been seen to correlate with sCS, from high weight at birth ≥ 4000 g (OR 1.61–2.91) [2, 82] to very low birth weight < 2500 g (OR = 1.5–2.32) [29, 102]), also to breech presentation (OR = 2.39) [63, 102].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
The Results (page unavailable) report that low birth weight was associated with increased craniosynostosis risk when all suture types were analyzed together. The passages in our copy do not establish the <2500 g cutoff or the claimed odds-ratio range of 1.5–2.32. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [102] Singer S, Bower C, Southall P, Goldblatt J (1999) Craniosynostosis in Western Australia, 1980–1994: a population-based study. Am J Med Genet 83:382–387. https://doi.org/10.1002/(sici)1096-8628(19990423)83:5%3C382::aid-ajmg8%3E3.0.co;2-a source
- Findingcitation
Advanced maternal age (>35 years) is highly correlated with sagittal suture fusion, with OR ranging from 2.01 to 2.32.
“Firstly, advanced maternal age (> 35 years) has been found to highly correlate with sagittal suture fusion, with an OR ranging from 2.01 to 2.32 [2, 82, 93, 102], while young maternal age has a protective effect OR 0.6 [56].”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [2] Boulet SL, Rasmussen SA, Honein MA (2008) A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 146:984–991. https://doi.org/10.1002/ajmg.a.32208 source
- cites [82] Lee HQ, Hutson JM, Wray AC et al (2012) Changing epidemiology of nonsyndromic craniosynostosis and revisiting the risk factors. J Craniofac Surg 23:1245–1251. https://doi.org/10.1097/SCS.0b013e318252d893 source
- cites [93] Rasmussen SA, Yazdy MM, Carmichael SL et al (2007) Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 110:369–377. https://doi.org/10.1097/01.AOG.0000270157.88896.76 source
The Results (page unavailable) say mothers of infants with craniosynostosis were more likely to be older, supporting an association with maternal age in general. They do not report an age-over-35 association specifically for sagittal suture fusion or an age-related OR of 2.01–2.32; the reported sagittal OR of 2.11 concerns maternal thyroid disease. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [102] Singer S, Bower C, Southall P, Goldblatt J (1999) Craniosynostosis in Western Australia, 1980–1994: a population-based study. Am J Med Genet 83:382–387. https://doi.org/10.1002/(sici)1096-8628(19990423)83:5%3C382::aid-ajmg8%3E3.0.co;2-a source
- Findingcitation
Fertility treatments correlate with increased presence of only sagittal synostosis if there is a twin gestation, with OR 1.6.
“It has been reported also that fertility treatments correlate to an increased presence of only sagittal synostosis if there is a twin gestation OR 1.6 [29].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
The Discussion (page unavailable) reports an association between plurality and sagittal synostosis when cases involving fertility treatments were included. It does not establish that fertility treatments themselves increase sagittal synostosis risk in twin gestations. The Results (page unavailable) instead give an adjusted OR of 2.1 for sagittal cases among twins or higher-order births after mothers who had fertility treatments were excluded, not the claimed OR of 1.6. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Lower risks of sCS have been observed in Hispanic individuals (OR = 0.4).
“lower risks have been observed in black (OR = 0.2), Hispanic (OR = 0.4), and other racial or ethnic groups (OR = 0.6) [56, 96]”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
The Results say that risk of coronal synostosis was not reduced among infants of Hispanic mothers, implying a reduction for at least some other suture types. But the available Results passages do not give an OR of 0.4 for Hispanic mothers or establish that estimate for craniosynostosis overall. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [96] Schraw JM, Woodhouse JP, Langlois PH et al (2021) Risk factors and time trends for isolated craniosynostosis. Birth Defects Res 113:43–54. https://doi.org/10.1002/bdr2.1824 source
The Results section reports lower prevalence of isolated craniosynostosis among offspring of Hispanic women than among offspring of non-Hispanic white women. It describes prevalence ratios, however, and the passages do not substantiate the claimed OR of 0.4. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Lower risks of sCS have been observed in other racial or ethnic groups (OR = 0.6).
“lower risks have been observed in black (OR = 0.2), Hispanic (OR = 0.4), and other racial or ethnic groups (OR = 0.6) [56, 96]”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
- cites [96] Schraw JM, Woodhouse JP, Langlois PH et al (2021) Risk factors and time trends for isolated craniosynostosis. Birth Defects Res 113:43–54. https://doi.org/10.1002/bdr2.1824 source
The Results (Risk Factors for Isolated Craniosynostosis; page unavailable) report lower prevalence among offspring of non-Hispanic Black and Hispanic women relative to offspring of non-Hispanic White women. Our copy does not report a lower risk for a separate ‘other’ racial or ethnic group or an OR of 0.6; it describes prevalence ratios rather than odds ratios. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Several studies consistently report a higher prevalence of sCS among individuals of white race.
“Several studies consistently report a higher prevalence among individuals of white race [29, 93]”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
- cites [93] Rasmussen SA, Yazdy MM, Carmichael SL et al (2007) Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 110:369–377. https://doi.org/10.1097/01.AOG.0000270157.88896.76 source
The Results report that mothers of infants with craniosynostosis were more likely than control mothers to be non-Hispanic white; the accompanying table gives 72.9% versus 60.0%. The paper does not report this race comparison specifically for sCS, and this single study cannot establish that several studies consistently found it. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Lower risks of sCS have been observed in black individuals (OR = 0.2).
“lower risks have been observed in black (OR = 0.2), Hispanic (OR = 0.4), and other racial or ethnic groups (OR = 0.6) [56, 96]”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
The Results section reports lower odds of craniosynostosis among infants born to Black mothers, but gives an adjusted OR of 0.3 (95% CI 0.2–0.4), not the claimed OR of 0.2. The reported estimate also excludes mothers who reported thyroid disease. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [96] Schraw JM, Woodhouse JP, Langlois PH et al (2021) Risk factors and time trends for isolated craniosynostosis. Birth Defects Res 113:43–54. https://doi.org/10.1002/bdr2.1824 source
The Results section reports lower prevalence of isolated craniosynostosis among offspring of non-Hispanic Black women than among offspring of non-Hispanic White women. It reports prevalence ratios, not the claimed odds ratio of 0.2; the claim also describes the group as Black individuals rather than offspring classified by maternal race/ethnicity. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Even among analytical studies, substantial heterogeneity in study design, exposure assessment, and outcome reporting complicates comparisons across cohorts.
“Even among analytical studies, substantial heterogeneity in study design, exposure assessment, and outcome reporting complicates comparisons across cohorts [10].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [10] Johnson D, Wilkie AOM (2011) Craniosynostosis. Eur J Hum Genet 19:369–376. https://doi.org/10.1038/ejhg.2010.235 source
The Clinical Overview describes heterogeneity in craniosynostosis causes and presentation, not heterogeneity among analytical studies. The Genetic counselling/risk assessment section notes a limitation of older epidemiological studies, but does not address differences in study design, exposure assessment, or outcome reporting across cohorts. Searches for those terms and for comparisons between studies found no supporting passage in our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measured
- Findingown data
Foetal constraint is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients, accounting for 12.6% of genetically tested individuals with sCS.
“Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients, accounting for 12.6% of genetically tested individuals with sCS.”
Quote in the paperSubstantial claim - Findingown data
A pathogenic germline mutation was reported for 259 patients (12.6%) out of 2060 sequenced and genetically tested patients from 2636 identified patients with sCS.
“A pathogenic germline mutation was reported for 259 patients (12.6%) out of 2060 (75.9%) sequenced and genetically tested patients from 2636 identified patients with sCS.”
Quote in the paperSubstantial claim - Findingown data
Advanced maternal age is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Male sex is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
11,086 patients were diagnosed with sCS, representing 42.8% of included patients.
“with 11,086 diagnosed with sCS (42.8%)”
- Also stated in: § Study characteristics · plain
“among whom 11,086 were diagnosed with sagittal synostosis (42.8%)”
Quote in the paperNot a substantial claim - Also stated in: § Study characteristics · plain
- Findingown data
Environmental and perinatal factors were more consistently reported across large population-based and case-control studies.
“Environmental and perinatal factors were more consistently reported across large population-based and case-control studies.”
Quote in the paperSubstantial claim - Findingown data
Effect sizes for the frequently associated environmental and perinatal factors varied across studies.
“although effect sizes varied across studies”
Quote in the paperNot a substantial claim - Findingown data
Maternal smoking is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Fertility treatments are frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Abnormal birth weight is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Thyroid dysfunction is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
Prematurity is frequently associated with sCS.
“Frequently associated factors included male sex, advanced maternal age, maternal smoking, thyroid dysfunction, fertility treatments, foetal constraint, prematurity, and abnormal birth weight, although effect sizes varied across studies.”
Quote in the paperNot a substantial claim - Findingown data
25,877 patients were included in the review.
“Overall, 25,877 patients were included”
- Also stated in: § Study characteristics · plain
“The 97 records passing full-text review included 25,877 patients”
Quote in the paperNot a substantial claim - Also stated in: § Study characteristics · plain
- Findingcitation
Mutations in the classical CS genes are relatively uncommon in apparently isolated sCS.
“Mutations in the classical CS genes are relatively uncommon in apparently isolated sCS.”
Quote in the paperSubstantial claim - Findingown data
Most excluded studies addressed syndromic forms of craniosynostoses, multiple suture craniosynostoses, or non-sagittal synostoses.
“Most excluded studies addressed syndromic forms of craniosynostoses, multiple suture craniosynostoses, or non-sagittal synostoses and were therefore not pertinent to the aim of comparing the two etiological domains in sCS.”
Quote in the paperNot a substantial claim - Findingown data
Among the included studies, 66 demonstrated involvement of genetic factors.
“Studies that demonstrated the involvement of genetic factors were 66, of which 31 were reported as case study, case report, case series; 34 were reported as observational retrospective, cohort, case control; and 1 study was an experimental functional study.”
Quote in the paperNot a substantial claim - Findingcitation
Synonymous or common variants of FGFR3 have not shown clear pathogenic relevance in sCS.
“In contrast, synonymous or common variants of FGFR3 have not shown clear pathogenic relevance, emphasizing the need to distinguish true disease-associated findings from background polymorphisms [23, 42].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] Anderson PJ, Netherway DJ, McGlaughlin K, David DJ (2007) Intracranial volume measurement of sagittal craniosynostosis. J Clin Neurosci 14:455–458. https://doi.org/10.1016/j.jocn.2006.07.001 source
- cites [42] Anderson PJ, Cox TC, Roscioli T et al (2007) Somatic FGFR and TWIST mutations are not a common cause of isolated nonsyndromic single suture craniosynostosis. J Craniofac Surg 18:312–314. https://doi.org/10.1097/scs.0b013e31802d6e76 source
- Findingreasoning
The available literature on sCS is characterized by a predominance of descriptive and observational study designs.
“Overall, the available literature is characterized by a predominance of descriptive and observational study designs, reflecting the rarity and heterogeneity of the condition.”
Quote in the paperNot a substantial claim- Rests on an assumption: sCS is a rare and heterogeneous condition.
- Findingcitation
Higher parental educational level (≥15 years) is associated with increased risk of sCS, with reported odds ratios ranging from 1.6 to 3.3 for maternal education and up to 4.4 for paternal education.
“Interestingly, higher parental educational level (≥ 15 years of education) has been associated with an increased risk of sCS, with reported odds ratios ranging from 1.6 to 3.3 for maternal education [15] and up to 4.4 for paternal education [26].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15] Källén K (1999) Maternal smoking and craniosynostosis. Teratology 60:146–150. https://doi.org/10.1002/(sici)1096-9926(199909)60:3%3C146::aid-tera10%3E3.3.co;2-v source
- cites [26] Zeiger JS, Beaty TH, Hetmanski JB et al (2002) Genetic and environmental risk factors for sagittal craniosynostosis. J Craniofac Surg 13:602–606. https://doi.org/10.1097/00001665-200209000-00002 source
- Findingcitation
Advanced paternal age (>40 years) has been found to pose as a risk factor for sCS in one article, with OR=2.11.
“Only in one article advanced paternal age (> 40 years) has been found to pose as a risk factor for sCS, with an OR = 2.11 [102].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [102] Singer S, Bower C, Southall P, Goldblatt J (1999) Craniosynostosis in Western Australia, 1980–1994: a population-based study. Am J Med Genet 83:382–387. https://doi.org/10.1002/(sici)1096-8628(19990423)83:5%3C382::aid-ajmg8%3E3.0.co;2-a source
- Findingcitation
High weight at birth ≥4000 g is correlated with sCS, with OR 1.61-2.91.
“At birth, there are some phenotypes that has been seen to correlate with sCS, from high weight at birth ≥ 4000 g (OR 1.61–2.91) [2, 82] to very low birth weight < 2500 g (OR = 1.5–2.32) [29, 102]), also to breech presentation (OR = 2.39) [63, 102].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Boulet SL, Rasmussen SA, Honein MA (2008) A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A 146:984–991. https://doi.org/10.1002/ajmg.a.32208 source
- cites [82] Lee HQ, Hutson JM, Wray AC et al (2012) Changing epidemiology of nonsyndromic craniosynostosis and revisiting the risk factors. J Craniofac Surg 23:1245–1251. https://doi.org/10.1097/SCS.0b013e318252d893 source
- Findingcitation
Breech presentation is correlated with sCS, with OR=2.39.
“At birth, there are some phenotypes that has been seen to correlate with sCS, from high weight at birth ≥ 4000 g (OR 1.61–2.91) [2, 82] to very low birth weight < 2500 g (OR = 1.5–2.32) [29, 102]), also to breech presentation (OR = 2.39) [63, 102].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [63] Farooq S, Morton J, Lloyd M, Krishna ST (2020) The influence of epigenetic factors in four pairs of twins with non-syndromic craniosynostosis. J Craniofac Surg 31:283–285. https://doi.org/10.1097/SCS.0000000000006064 source
- cites [102] Singer S, Bower C, Southall P, Goldblatt J (1999) Craniosynostosis in Western Australia, 1980–1994: a population-based study. Am J Med Genet 83:382–387. https://doi.org/10.1002/(sici)1096-8628(19990423)83:5%3C382::aid-ajmg8%3E3.0.co;2-a source
- Findingown data
There is marked male predominance in sCS (sum of all studies 5156 male and 1800 female).
“A well-known and consistent finding across the studies analyzed in this review is the marked male predominance (sum of all studies 5156 male and 1800 female) in sCS.”
Quote in the paperNot a substantial claim - Findingnone given
Pregnancies without regular supplement intake have an increased risk of sCS, with OR of 1.4.
“An increased risk of sCS has been reported in pregnancies without a regular supplement intake, with an OR of 1.4.”
Quote in the paperNot a substantial claim - Findingown data
Many studies of environmental risk factors for sCS are underpowered due to limited sample sizes.
“Many studies, including case reports, case series, and small observational studies, are underpowered due to limited sample sizes, with only 29 out of 96 cohorts including more than 200 participants.”
Quote in the paperSubstantial claim - Findingreasoning
The available evidence is based on study designs with different risks of bias and different levels of methodological robustness.
“This heterogeneity is considered a limitation, and the findings should be interpreted cautiously because the available evidence is based on study designs with different risks of bias and different levels of methodological robustness.”
Quote in the paperSubstantial claim - Findingown data
Only 29 out of 96 cohorts included more than 200 participants.
“Many studies, including case reports, case series, and small observational studies, are underpowered due to limited sample sizes, with only 29 out of 96 cohorts including more than 200 participants.”
Quote in the paperSubstantial claim - Findingnone given
The included evidence derives from heterogeneous study designs and levels of evidence, including case reports, cohort studies, GWAS, and population-based studies.
“The included evidence derives from heterogeneous study designs and levels of evidence, including case reports, cohort studies, GWAS, and population-based studies.”
Quote in the paperSubstantial claim - Findingnone given
Despite variability in diagnostic approaches, a consistent pattern in the identified genes was observed across studies.
“Despite the variability in diagnostic approaches, which may have influenced the reported genetic diagnostic yield, a consistent pattern in the identified genes was observed across studies.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Epidemiological evidence suggests that environmental and perinatal influences may also contribute to sCS pathogenesis.
“whereas epidemiological evidence suggests that environmental and perinatal influences may also contribute to disease pathogenesis”
Quote in the paperSubstantial claim - Interpretationreasoning
The available evidence does not support either genetic or environmental factors as individually deterministic drivers of sCS development.
“the available evidence does not support either genetic or environmental factors as individually deterministic drivers of disease development”
Quote in the paperSubstantial claim - Interpretationreasoning
The evidence supports a multifactorial model for sCS, in which rare genetic susceptibility and non-genetic influences likely interact in etiopathogenesis rather than reflecting a single dominant aetiology.
“Overall, the evidence synthesized in this review supports a multifactorial model for sCS, in which rare genetic susceptibility and non-genetic influences likely interact in the etiopathogenesis of the condition rather than reflecting a single dominant aetiology.”
Quote in the paperSubstantial claim - Interpretationown data
Most sCS cases lack identifiable germline mutations in key signalling pathways.
“most cases lack identifiable germline mutations in key signalling pathways”
Quote in the paperSubstantial claim- Rests on an assumption: The genetic testing methodologies used in the included studies would have detected pathogenic germline variants in key signalling pathways if present.
- Interpretationown data
Identifiable germline genetic causes appear to account for only a minority of sCS cases.
“Identifiable germline genetic causes appear to account for only a minority of sCS cases”
Quote in the paperSubstantial claim- Rests on an assumption: The germline variants reported by included studies are correctly classified as pathogenic or likely pathogenic and are causally related to sCS.
- Rests on an assumption: The genetic testing methodologies used in the included studies would have detected pathogenic germline variants in key signalling pathways if present.
- Interpretationcitation
Rare variants in ALX4 and IGF1R support a contribution of genes involved in osteoblast differentiation and suture growth to sCS.
“Likewise, rare variants in ALX4 and IGF1R support a contribution of genes involved in osteoblast differentiation and suture growth [59, 62119”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 59, 62119
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Different genetic variations may converge on shared downstream mechanisms promoting premature osteogenic commitment of osteoblast precursors within the sagittal suture.
“These data suggest that different genetic variations may converge on shared downstream mechanisms promoting premature osteogenic commitment of osteoblast precursors within the sagittal suture.”
Quote in the paperSubstantial claim - Interpretationcitation
Non-coding, regulatory, and structural genomic changes are relevant to sCS disease susceptibility.
“Additional studies also indicate that non-coding, regulatory, and structural genomic changes are relevant to disease susceptibility.”
Quote in the paperSubstantial claim - Interpretationreasoning
The genetic architecture of sCS differs from that of the more recognizable monogenic CS syndromes.
“Taken together, these studies suggest that the genetic architecture of sCS differs from that of the more recognizable monogenic CS syndromes.”
Quote in the paperSubstantial claim - Interpretationreasoning
Genes implicated in sCS do not appear random but cluster in a restricted number of signalling pathways central to osteogenesis and cranial morphogenesis.
“Despite this broad heterogeneity, the genes implicated in sCS do not appear random. Rather, they cluster in a restricted number of signalling pathways central to osteogenesis and cranial morphogenesis.”
Quote in the paperSubstantial claim - Interpretationreasoning
sCS is not driven in most cases by recurrent high-penetrance mutations.
“Rather than being driven, in most cases, by recurrent high-penetrance mutations, sCS appears to arise from a broad spectrum of rare coding variants, structural rearrangements, regulatory alterations, and susceptibility alleles that converge on a limited number of developmental pathways controlling cranial suture patency.”
Quote in the paperSubstantial claim - Interpretationreasoning
sCS appears to arise from a broad spectrum of rare coding variants, structural rearrangements, regulatory alterations, and susceptibility alleles that converge on a limited number of developmental pathways controlling cranial suture patency.
“Rather than being driven, in most cases, by recurrent high-penetrance mutations, sCS appears to arise from a broad spectrum of rare coding variants, structural rearrangements, regulatory alterations, and susceptibility alleles that converge on a limited number of developmental pathways controlling cranial suture patency.”
Quote in the paperSubstantial claim - Interpretationreasoning
Altered phosphate handling, bone metabolism, and cranial compliance may predispose specifically to premature sagittal suture closure.
“These observations are relevant because they indicate that altered phosphate handling, bone metabolism, and cranial compliance may predispose specifically to premature sagittal suture closure.”
Quote in the paperSubstantial claim - Interpretationreasoning
At least a subset of cases initially classified as non-syndromic may represent attenuated or atypical presentations within a wider syndromic continuum.
“This supports the view that at least a subset of cases initially classified as non-syndromic may in fact represent attenuated or atypical presentations within a wider syndromic continuum.”
Quote in the paperSubstantial claim - Interpretationreasoning
Several moderately penetrant variants may interact to increase susceptibility to sCS without being individually sufficient to cause disease.
“While individually difficult to interpret, these findings support an oligogenic or multifactorial model, in which several moderately penetrant variants may interact to increase susceptibility without being individually sufficient to cause disease.”
Quote in the paperSubstantial claim - Interpretationcitation
Exposure to metals such as tin, nickel, and chromium may represent a risk throughout pregnancy due to their effects on osteoblasts.
“In contrast, exposure to metals such as tin, nickel, and chromium may represent a risk throughout pregnancy due to their effects on osteoblasts [114].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Weng Z, Xu C, Chen X et al (2024) Sp1-activated FGFR2 is involved in early-life exposure to nickel-induced craniosynostosis by regulating the ERK1/2 signaling pathway. Environ Int 184:108477. https://doi.org/10.1016/j.envint.2024.108477 source
- Interpretationreasoning
Reports of twin pairs in which both are affected by CS but with different sutures involved are particularly informative.
“Because monozygotic twins share (nearly) identical genetic backgrounds, reports of twin pairs in which both are affected by CS but with different sutures involved are particularly informative.”
Quote in the paperNot a substantial claim- Rests on an assumption: Monozygotic twins share nearly identical genetic backgrounds.
- Interpretationreasoning
Multiple components likely interact in the etiopathogenesis of sCS.
“In conclusion, the evidence synthesized in this review supports a multifactorial model for sCS, in which neither genetic nor environmental factors appear to act as individually deterministic drivers in the etiopathogenesis of sCS, supporting a model in which multiple components likely interact.”
Quote in the paperSubstantial claim - Interpretationreasoning
Environmental factors may act as modifiers or triggers in genetically susceptible individuals, influencing the timing or extent of sagittal suture fusion.
“Environmental factors may therefore act as modifiers or triggers in genetically susceptible individuals, influencing the timing or extent of sagittal suture fusion.”
Quote in the paperSubstantial claim - Interpretationreasoning
The marked male predominance, together with associations involving maternal age, pregnancy conditions, and modifiable exposures such as smoking, micronutrient intake, and environmental pollutants, highlights the importance of both biological and external determinants acting during critical windows of cranial development.
“The marked male predominance, together with associations involving maternal age, pregnancy conditions, and modifiable exposures such as smoking, micronutrient intake, and environmental pollutants, highlights the importance of both biological and external determinants acting during critical windows of cranial development.”
Quote in the paperSubstantial claim - Interpretationreasoning
Current data indicate that sCS likely arises from a complex interplay between genetic susceptibility and environmental influences.
“Rather than supporting a strict dichotomy between genetic and environmental aetiologies, current data indicate that sCS likely arises from a complex interplay between genetic susceptibility and environmental influences.”
Quote in the paperSubstantial claim - Interpretationreasoning
Race/ethnicity associations may act as proxies for underlying differences in environmental exposures, socio-economic conditions, access to prenatal care, nutritional factors, or gene-environment interactions that vary across populations.
“Importantly, these associations are unlikely to reflect race-specific biological mechanisms per se but rather may act as proxies for underlying differences in environmental exposures, socio-economic conditions, access to prenatal care, nutritional factors, or gene-environment interactions that vary across populations.”
Quote in the paperSubstantial claim - Interpretationreasoning
Twin studies provide some of the strongest evidence supporting gene-environment interplay in the development of sCS.
“Twin studies provide some of the strongest evidence supporting gene-environment interplay in the development of sCS.”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The heterogeneity of included study designs and levels of evidence is a limitation.
“This heterogeneity is considered a limitation, and the findings should be interpreted cautiously because the available evidence is based on study designs with different risks of bias and different levels of methodological robustness.”
Quote in the paperSubstantial claim - Interpretationreasoning
The precise causal mechanisms of sCS remain incompletely understood.
“Despite this, the precise causal mechanisms remain incompletely understood.”
Quote in the paperSubstantial claim - Interpretationnone given
Overall, sCS appears to result from a complex interplay between rare genetic variants and environmental influences, rather than a single predominant etiological mechanism.
“Overall, sCS appears to result from a complex interplay between rare genetic variants and environmental influences, rather than a single predominant etiological mechanism.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The identification of rare and heterogeneous genetic variants, coupled with the absence of consistent high-penetrance mutations, implies that genetic predisposition alone is often insufficient to cause disease.
“The identification of rare and heterogeneous genetic variants, coupled with the absence of consistent high-penetrance mutations, implies that genetic predisposition alone is often insufficient to cause disease.”
Quote in the paperSubstantial claim - Study design and conductnone given
Differences in study types and sequencing methodologies across the included records resulted in challenging cross-study comparisons.
“The differences in study types, sequencing methodologies across the included records, resulted in challenging cross-study comparisons.”
Quote in the paperSubstantial claim - Interpretationreasoning
The associations between race/ethnicity and sCS are unlikely to reflect race-specific biological mechanisms per se.
“Importantly, these associations are unlikely to reflect race-specific biological mechanisms per se but rather may act as proxies for underlying differences in environmental exposures, socio-economic conditions, access to prenatal care, nutritional factors, or gene-environment interactions that vary across populations.”
Quote in the paperSubstantial claim
- May combine two claims. 45
- Classified as probably not a substantial claim. 29
May combine two claims.
PremisecitationThe relative contribution of genetic and environmental factors in the pathogenesis of sagittal synostosis remains unclear, and current evidence is fragmented and often limited by small sample sizes or investigation of isolated risk factors.
“Despite these findings, the relative contribution of genetic and environmental factors in the pathogenesis of sagittal synostosis remains unclear. Current evidence is fragmented and often limited by small sample sizes or the investigation of isolated risk factors [10, 29, 31, 36].”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [10] Johnson D, Wilkie AOM (2011) Craniosynostosis. Eur J Hum Genet 19:369–376. https://doi.org/10.1038/ejhg.2010.235 source
The Clinical Overview (page not specified) identifies both genetic and environmental predispositions to craniosynostosis, while Genetic counselling/risk assessment describes uncertainty in estimates for sagittal synostosis. Genetic testing strategy notes relatively small numbers in some tested groups. The paper does not specifically assess the relative genetic and environmental contributions to sagittal synostosis or characterize the overall evidence as fragmented and focused on isolated risk factors. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
The Introduction says no population-based study had directly assessed fetal-constraint factors in nonsyndromic craniosynostosis, and the Discussion says the underlying causes need further investigation. This supports uncertainty and investigation of selected risk factors, but the paper does not characterize the evidence on sagittal synostosis generally as fragmented or often limited by small samples; it describes its own study as the largest population-based study to date. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [31] Carmichael SL, Ma C, Rasmussen SA et al (2008) Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol 82:78–85. https://doi.org/10.1002/bdra.20426 source
- cites [36] Gedzelman E, Meador KJ (2012) Antiepileptic drugs in women with epilepsy during pregnancy. Ther Adv Drug Saf 3:71–87. https://doi.org/10.1177/2042098611433192 source
May combine two claims.
PremisecitationBoth genetic predisposition and environmental influences contribute to non-syndromic craniosynostosis aetiology.
“Both genetic predisposition and environmental influences contribute to NCS aetiology [12, 13].”
- Also stated in: § Introduction · hedged
“Both genetic predisposition and environmental factors are thought to contribute to the aetiology of non-syndromic sCS [12, 13].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [12] Greenwood J, Flodman P, Osann K et al (2014) Familial incidence and associated symptoms in a population of individuals with nonsyndromic craniosynostosis. Genet Med 16:302–310. https://doi.org/10.1038/gim.2013.134 source
The Introduction describes nonsyndromic craniosynostosis as hypothesized to involve genetic and environmental influences. It reports evidence for a genetic role and associations with several environmental factors, but says the precise causes are not fully understood. The claim presents their contribution to aetiology more definitively than the source does. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [13] Cohen MM, MacLean RE (2000) Craniosynostosis: diagnosis, evaluation, and management, 2nd ed. Oxford University Press, New York
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § Introduction · hedged
May combine two claims.
PremisecitationEpidemiological studies have identified demographic and environmental associations with sCS, including male sex, advanced maternal age, and specific prenatal exposures such as maternal smoking, hypoxia-related conditions, sodium valproate, retinoic acid, antidepressants, and assisted reproductive technologies.
“Epidemiological studies have identified several demographic and environmental associations, such as male sex, advanced maternal age, and specific prenatal exposures including maternal smoking, hypoxia-related conditions, sodium valproate, retinoic acid, antidepressants, and assisted reproductive technologies [15, 26–35].”
Quote in the paperNot a substantial claim4 of 10 sources checked- cites [15] Källén K (1999) Maternal smoking and craniosynostosis. Teratology 60:146–150. https://doi.org/10.1002/(sici)1096-9926(199909)60:3%3C146::aid-tera10%3E3.3.co;2-v source
- cites [26] Zeiger JS, Beaty TH, Hetmanski JB et al (2002) Genetic and environmental risk factors for sagittal craniosynostosis. J Craniofac Surg 13:602–606. https://doi.org/10.1097/00001665-200209000-00002 source
- cites [27] Reefhuis J, Honein MA, Shaw GM, Romitti PA (2003) Fertility treatments and craniosynostosis: California, Georgia, and Iowa, 1993–1997. Pediatrics 111:1163–1166 source
- cites [28] Reefhuis J, Honein MA (2004) Maternal age and non-chromosomal birth defects, Atlanta—1968–2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol 70:572–579. https://doi.org/10.1002/bdra.20065 source
- cites [29] Sanchez-Lara PA, Carmichael SL, Graham JM Jr et al (2010) Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A 152:394–400. https://doi.org/10.1002/ajmg.a.33246 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [30] Gill SK, Broussard C, Devine O et al (2012) Association between maternal age and birth defects of unknown etiology - United States, 1997–2007. Birth Defects Res A Clin Mol Teratol 94:1010–1018. https://doi.org/10.1002/bdra.23049 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [31] Carmichael SL, Ma C, Rasmussen SA et al (2008) Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol 82:78–85. https://doi.org/10.1002/bdra.20426 source
- cites [32] Lajeunie E, Barcik U, Thorne JA et al (2001) Craniosynostosis and fetal exposure to sodium valproate. J Neurosurg 95:778–782. https://doi.org/10.3171/jns.2001.95.5.0778 source
- cites [33] James AW, Levi B, Xu Y et al (2010) Retinoic acid enhances osteogenesis in cranial suture–derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosis. Plast Reconstr Surg 125:1352–1361. https://doi.org/10.1097/PRS.0b013e3181d62980 source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [34] Alwan S, Reefhuis J, Rasmussen SA et al (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684–2692. https://doi.org/10.1056/NEJMoa066584 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSagittal craniosynostosis is the most common form of non-syndromic craniosynostosis, accounting for 40-60% of all craniosynostosis cases, with an estimated incidence of 1:5000 live births.
“Among NCS, sagittal CS (sCS) is the most common form, accounting for 40–60% of all CS cases, with an estimated incidence of 1:5000 live births [14].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [14] Spazzapan P, Velnar T (2024) Isolated sagittal craniosynostosis: a comprehensive review. Diagnostics 14:435. https://doi.org/10.3390/diagnostics14040435 source
May combine two claims.
InterpretationcitationALX4 may be a potential target of TWIST1 or TCF12, both of which are required for calvarial development and suture closure.
“ALX4 may be a potential target of TWIST1 or even TCF12, both of which are required for calvarial development and suture closure [127, 128].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [127] Loebel DAF, O’Rourke MP, Steiner KA, Banyer J, Tam PPL (2002) Isolation of differentially expressed genes from wild-type and Twist mutant mouse limb buds. Genesis 33:103–113 source
- cites [128] Fan X, Waardenberg AJ, Demuth M, Osteil P, Sun JQJ, Loebel DAF et al (2020) TWIST1 homodimers and heterodimers orchestrate lineage-specific differentiation. Mol Cell Biol 40:e00663–19 source
The Introduction (p. 4) describes TWIST1 as critical for craniofacial development and links altered TWIST1 function to craniosynostosis. The TCF12–TWIST1 section (p. 13) says the two act synergistically in cranial tissue development and discusses skull-suture regulation. Our copy does not identify ALX4 as a potential target of either factor (searched: ALX4), so the central proposed target relationship is unsupported. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationStudy selection was conducted in two stages by two independent reviewers using Rayyan systematic review software.
“Study selection was conducted in two stages by two independent reviewers (V. DG and D. D. T.) using Rayyan systematic review software [39]: stage 1, title, and abstract screening: All retrieved citations were independently screened by both reviewers using the prespecified eligibility criteria.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [39] Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4 source
May combine two claims.
InterpretationcitationIncreasing evidence implicates WNT/β-catenin signalling through AXIN1, AXIN2, and RUNX2 in sCS, suggesting that dysregulated osteoblast differentiation may be a recurrent biological mechanism.
“Similarly, increasing evidence implicates WNT/β-catenin signalling through AXIN1, AXIN2, and RUNX2, suggesting that dysregulated osteoblast differentiation may be a recurrent biological mechanism in sCS [58, 105, 118, 121].”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [58] Cuellar A, Bala K, Di Pietro L et al (2020) Gain-of-function variants and overexpression of RUNX2 in patients with nonsyndromic midline craniosynostosis. Bone 137:115395. https://doi.org/10.1016/j.bone.2020.115395 source
The Introduction identifies Wnt signalling as one pathway converging on RUNX2, and the Conclusions suggest that RUNX2 overexpression in osteogenic precursors could accelerate differentiation and cause premature suture fusion. This supports the RUNX2 and dysregulated-differentiation part of the claim, but the paper does not establish the specific WNT/β-catenin mechanism through AXIN1 and AXIN2 in nonsyndromic craniosynostosis. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [105] Timberlake AT, Hemal K, Gustafson JA et al (2024) AXIN1 mutations in nonsyndromic craniosynostosis. J Neurosurg Pediatr 34:246–251. https://doi.org/10.3171/2024.5.PEDS24115 source
- cites [118] Xu J, Yan Q, Song C et al (2021) An Axin2 mutation and perinatal risk factors contribute to sagittal craniosynostosis: evidence from a Chinese female monochorionic diamniotic twin family. Hereditas 158:20. https://doi.org/10.1186/s41065-021-00182-0 source
- cites [121] Yilmaz E, Mihci E, Guzel Nur B, Alper OM (2018) A novel AXIN2 gene mutation in sagittal synostosis. Am J Med Genet A 176:1976–1980. https://doi.org/10.1002/ajmg.a.40373 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationALX4 is involved in craniofacial development.
“Particularly, ALX4 is involved in craniofacial development [62], anda variant in ALX4 was found associated with a moderate form of frontonasal dysplasia type 1 with minute parietal foramina [126].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [62] Di Rocco F, Rossi M, Verlut I et al (2023) Clinical interest of molecular study in cases of isolated midline craniosynostosis. Eur J Hum Genet 31, 621–628 (2023). https://doi.org/10.1038/s41431-023-01295-y source
May combine two claims.
FindingcitationVariants in TWIST1, FGFR1, and FGFR2 have been described in sCS, although each accounts for only a minor proportion of cases.
“Variants in TWIST1, FGFR1, and FGFR2 have been described, although each accounts for only a minor proportion of cases [62, 98, 120].”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [62] Di Rocco F, Rossi M, Verlut I et al (2023) Clinical interest of molecular study in cases of isolated midline craniosynostosis. Eur J Hum Genet 31, 621–628 (2023). https://doi.org/10.1038/s41431-023-01295-y source
The Introduction (page unavailable) describes TWIST1 and FGFR2 variants as rare in isolated sagittal craniosynostosis, supporting their description and minor contribution. Neither that passage nor the searched passages on FGFR1 identify FGFR1 variants in these cases, so the claim is unsupported for that gene. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [98] Seto ML, Hing AV, Chang J et al (2007) Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. Am J Med Genet A 143:678–686. https://doi.org/10.1002/ajmg.a.31630 source
- cites [120] Ye X, Guilmatre A, Reva B et al (2016) Mutation screening of candidate genes in patients with nonsyndromic sagittal craniosynostosis. Plast Reconstr Surg 137:952–961. https://doi.org/10.1097/01.prs.0000479978.75545.ee source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductcitationThe PRISMA principle was used as an assessment tool, and PubMed was used to collect data.
“The PRISMA [38] principle was used as an assessment tool, using the PubMed database to collect data.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [38] Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71 source
May combine two claims.
InterpretationcitationAdditional convergence in sCS is seen in the Hedgehog pathway, involving ALX4, IHH, and RAB23, and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF, PTPN11, and MAP4K4.
“Additional convergence is seen in the Hedgehog pathway, involving ALX4, IHH, and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF, PTPN11, and MAP4K4 [61, 112, 122].”
Quote in the paperSubstantial claim2 of 6 sources checked- cites [46] Barroso E, Berges-Soria J, Benito-Sanz S et al (2015) Identification of the fourth duplication of upstream IHH regulatory elements, in a family with craniosynostosis Philadelphia type, helps to define the phenotypic characterization of these regulatory elements. Am J Med Genet A 167:902–906. https://doi.org/10.1002/ajmg.a.36811 source
- cites [72] Jenkins D, Seelow D, Jehee FS et al (2007) RAB23 mutations in Carpenter syndrome imply an unexpected role for hedgehog signaling in cranial-suture development and obesity. Am J Hum Genet 80:1162–1170. https://doi.org/10.1086/518047 source
- cites [77] Klopocki E, Lohan S, Brancati F et al (2011) Copy-number variations involving the IHH locus are associated with syndactyly and craniosynostosis. Am J Hum Genet 88:70–75. https://doi.org/10.1016/j.ajhg.2010.11.006 source
- cites [61] Davis AA, Zuccoli G, Haredy MM, et al (2019) RASopathy in patients with isolated sagittal synostosis. Glob Pediatr Health 6:2333794X19846774. https://doi.org/10.1177/2333794X19846774 source
The Background identifies RASopathies as MAPK-pathway disorders, and the Discussion reports isolated sagittal synostosis in patients with BRAF and PTPN11 variants. The paper does not report a MAP4K4 variant; the Hedgehog-pathway clause is attached to other citations. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [112] Ueda K, Yaoita M, Niihori T et al (2017) Craniosynostosis in patients with RASopathies: accumulating clinical evidence for expanding the phenotype. Am J Med Genet A 173:2346–2352. https://doi.org/10.1002/ajmg.a.38337 source
- cites [122] Yoon JG, Yu JW, Shim KW et al (2024) Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: expanding the genotype-phenotype relationship in RASopathies. Clin Genet 106:199–203. https://doi.org/10.1111/cge.14539 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationAMSTAR 2 appraisal tool was used to assess systematic review quality.
“AMSTAR 2 appraisal tool has been used to assess systematic review quality [37].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [37] Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E, Henry DA (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008 source
May combine two claims.
FindingcitationIntake of specific micronutrients is associated with reduced risk of sCS: riboflavin OR=0.5, vitamin B6 OR=0.4, vitamin E OR=0.6, and vitamin C OR=0.7.
“Conversely, intake of specific micronutrients has been associated with a reduced risk of sCS, including riboflavin (OR = 0.5), vitamin B6 (OR = 0.4), vitamin E (OR = 0.6), and vitamin C (OR = 0.7) [55].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [55] Carmichael SL, Rasmussen SA, Lammer EJ et al (2010) Craniosynostosis and nutrient intake during pregnancy. Birth Defects Res A Clin Mol Teratol 88:1032–1039. https://doi.org/10.1002/bdra.20717 source
The Results report the stated adjusted odds ratios for riboflavin (0.5), vitamin B6 (0.4), and vitamin E (0.6) for sagittal synostosis. They report a vitamin C ratio of ≤0.7, not the exact 0.7 attributed here; its highest-versus-lowest-quartile confidence interval did not exclude 1, although the continuous analysis found an association. These dietary analyses were restricted to mothers who took folic acid–containing supplements in the first trimester. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationA possible explanation for male predominance is sex-specific transcriptional factors that may alter osteoblast differentiation signals mainly in males, while sCS occurrence in females has different genetic risk profiles.
“A possible explanation of this effect has been linked to possible sex-specific transcriptional factor that may alter osteoblasts differentiation signal mainly on males, while sCS occurrence in females have different genetic risk profiles [91].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [91] Park SS, Beyer RP, Smyth MD et al (2015) Osteoblast differentiation profiles define sex specific gene expression patterns in craniosynostosis. Bone 76:169–176. https://doi.org/10.1016/j.bone.2015.03.001 source
The Conclusion links sex-specific gene expression correlated with osteoblast differentiation to the possible male predominance of sagittal and metopic craniosynostosis. It also suggests that females with sagittal synostosis may have different genetic risk profiles. It does not establish that sex-specific transcription factors alter differentiation signals; the evidence concerns correlated transcripts, not a demonstrated mechanism. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationSusceptibility loci near BMP2 and within BBS9, as well as functional evidence implicating ciliogenesis and primary cilium biology, are relevant to sagittal suture homeostasis.
“This is further reinforced by the identification of susceptibility loci near BMP2 and within BBS9, as well as functional evidence implicating ciliogenesis and primary cilium biology in sagittal suture homeostasis [44, 76].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [44] Barba M, Di Pietro L, Massimi L et al (2018) BBS9 gene in nonsyndromic craniosynostosis: role of the primary cilium in the aberrant ossification of the suture osteogenic niche. Bone 112:58–70. https://doi.org/10.1016/j.bone.2018.04.013 source
- cites [76] Justice CM, Yagnik G, Kim Y et al (2012) A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9. Nat Genet 44:1360–1364. https://doi.org/10.1038/ng.2463 source
The Abstract (page unavailable) reports replicated susceptibility loci near BMP2 and within BBS9. It also links BBS9 to ciliary transport and discusses primary-cilium signaling, but says that BBS9’s effect on suture fusion remains unknown. It does not provide functional evidence that ciliogenesis or primary cilia maintain sagittal suture homeostasis. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationDiscordant phenotypes in genetically identical twins carrying the same variant, as reported for AXIN2 and ERF, suggest that genetic predisposition alone may not fully determine the phenotype and that additional modifiers are likely involved.
“The observation of discordant phenotypes in genetically identical twins carrying the same variant, as reported for AXIN2 and ERF, further suggests that genetic predisposition alone may not fully determine the phenotype and that additional modifiers are likely involved [63, 118].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [63] Farooq S, Morton J, Lloyd M, Krishna ST (2020) The influence of epigenetic factors in four pairs of twins with non-syndromic craniosynostosis. J Craniofac Surg 31:283–285. https://doi.org/10.1097/SCS.0000000000006064 source
- cites [118] Xu J, Yan Q, Song C et al (2021) An Axin2 mutation and perinatal risk factors contribute to sagittal craniosynostosis: evidence from a Chinese female monochorionic diamniotic twin family. Hereditas 158:20. https://doi.org/10.1186/s41065-021-00182-0 source
May combine two claims.
FindingcitationMaternal thyroid disease is linked to increased risk of CS, with reported ORs ranging from 1.3 to 2.11.
“Maternal thyroid disease has also been linked to an increased risk of CS, with reported ORs ranging from 1.3 to 2.11 [56, 93], consistent with the well-established role of thyroid hormones in skeletal development.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [56] Carmichael SL, Ma C, Rasmussen SA et al (2015) Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A 167:701–707. https://doi.org/10.1002/ajmg.a.36953 source
The Results report an adjusted OR of 1.4 for maternal thyroid disease and craniosynostosis overall, supporting the stated link, although its 95% CI (0.9–1.9) includes 1. The paper does not report the claimed OR range of 1.3 to 2.11; its reported OR for multiple affected sutures is 3.0. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [93] Rasmussen SA, Yazdy MM, Carmichael SL et al (2007) Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 110:369–377. https://doi.org/10.1097/01.AOG.0000270157.88896.76 source
The Results report an association between maternal thyroid disease and craniosynostosis, but the overall adjusted OR is 2.47, outside the stated range. The paper reports an OR of 2.11 only for sagittal craniosynostosis; it does not report 1.3 as an OR for the overall association (Results; page not specified in our copy). (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Rests on an assumption: Thyroid hormones play a well-established role in skeletal development.
May combine two claims.
FindingcitationSchraw et al. found increased odds of patients coming from parents residing close to the US-Mexico border (aPR=1.29), and Somolan et al. showed a correlation with patients living in more rural areas.
“An example of the link between area of living and CS has been shown by Schraw et al., where they found increased changes of patients to come from parents residing close to the US-Mexico border (aPR = 1.29) [96], and by Somolan et al., showing a correlation with patients living in more rural areas [103].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [96] Schraw JM, Woodhouse JP, Langlois PH et al (2021) Risk factors and time trends for isolated craniosynostosis. Birth Defects Res 113:43–54. https://doi.org/10.1002/bdr2.1824 source
The Results (Risk Factors for Isolated Craniosynostosis by Subtype) report an aPR of 1.29 for sagittal synostosis among offspring of mothers residing in counties adjoining the U.S.–Mexico border. The citing sentence presents that figure as applying to craniosynostosis generally, but the paper reports a different association for coronal synostosis and none for metopic synostosis. The separately cited claim about rural areas is not attributed to Schraw et al. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [103] Somolan CV, Petchesi CD, Jurca C, Bembea M (2022) Clinical-epidemiological study of a cohort of 35 patients with craniosynostosis. Maedica (Bucur) 17:893–901. https://doi.org/10.26574/maedica.2022.17.4.893 source
The Outcomes section reports that 21 of 35 patients came from rural areas, compared with 14 from urban areas, and the Conclusions identify rural patients among the most frequently affected groups. These descriptive counts do not establish a correlation between rural residence and craniosynostosis; the paper does not list rural residence among its identified risk factors. The Schraw et al. finding is attributed to a different citation and is not assessed here. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationStudy designs such as case reports, case series, and small observational studies limit generalizability and causal inference, although they are useful for hypothesis generation.
“Although useful for hypothesis generation, these study designs limit generalizability and causal inference [12, 25].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [12] Greenwood J, Flodman P, Osann K et al (2014) Familial incidence and associated symptoms in a population of individuals with nonsyndromic craniosynostosis. Genet Med 16:302–310. https://doi.org/10.1038/gim.2013.134 source
The Introduction says prior studies of associated symptoms were limited by small sample sizes, and the Discussion cautions that this study’s findings may not reflect the target population. Those passages support a concern about generalizability, but the paper does not make the broader claim that case reports, case series, and small observational studies limit causal inference while serving as hypothesis generators. Page numbers were not available in our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [25] Clarke CM, Fok VT, Gustafson JA et al (2018) Single suture craniosynostosis: identification of rare variants in genes associated with syndromic forms. Am J Med Genet A 176:290–300. https://doi.org/10.1002/ajmg.a.38540 source
The Discussion (page unavailable) says the study identified candidate variants but did not establish causality; further functional studies would be needed. That supports the point about generating leads without establishing causation, but the paper does not discuss case reports, case series, or small observational studies as a class, or their limits on generalizability. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataA total of 1238 records were identified through the PubMed search.
“A total of 1238 records were identified, of which 97 studies met inclusion criteria after full-text review.”
- Also stated in: § Study selection · plain
“A total of 1238 articles were initially identified through the PubMed search.”
Quote in the paperNot a substantial claim- Also stated in: § Study selection · plain
May combine two claims.
Findingown dataIdentified variants were distributed across 125 genes, with recurrent findings in 25 genes.
“Identified variants were distributed across 125 genes, with recurrent findings in 25 genes.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingown data97 studies met inclusion criteria after full-text review.
“of which 97 studies met inclusion criteria after full-text review”
- Also stated in: § Study selection · plain
“Full-text assessment then led to a final selection of 97 articles that met the criteria of this review”
Quote in the paperSubstantial claim- Also stated in: § Study selection · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSeven included studies presented both genetic and environmental factors.
“Seven of these studies presented both genetic and environmental factor out of which 4 case-control study, 1 cohort study, 1 clinical and molecular family study, and 1 prospective study.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataGenetic investigations were reported in the majority of studies, whereas environmental determinants were assessed less consistently and primarily within epidemiological frameworks.
“Genetic investigations were reported in the majority of studies, whereas environmental determinants were assessed less consistently and primarily within epidemiological frameworks.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAmong the included studies, 25 focused on environmental engagement.
“Studies with a focus on environmental engagement were 25, out of which 2 were reported as case report, 1 case series, 3 as case-control study, 12 as population-based case-control study, 5 as retrospective study, 1 as prospective study, and 1 as twin study.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenMost reported variants occur in single individuals or small cohorts, whereas only a few genes recur across independent studies.
“This interpretation is consistent with the observation that most reported variants occur in single individuals or small cohorts, whereas only a few genes recur across independent studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data128 studies were considered sufficiently relevant after preliminary screening of titles and abstracts.
“As shown in Fig. 1, only 128 studies were considered sufficiently relevant after the preliminary screening of titles and abstracts.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe highest risk for PAH exposure is during the early months of pregnancy, with OR=1.76.
“The highest risk has been reported during the early months of pregnancy for PAH exposure (OR = 1.76).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationPaternal employment as mechanics/repairmen is associated with increased odds across multiple suture types (OR range: 1.8-3.0), whereas no association was observed for sagittal synostosis among fathers working in agriculture/forestry (OR=0.9).
“In this study, paternal employment as mechanics/repairmen was associated with increased odds across multiple suture types (OR range: 1.8–3.0), whereas no association was observed for sagittal synostosis among fathers working in agriculture/forestry (OR = 0.9) [52].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Bradley CM, Alderman BW, Williams MA et al (1995) Parental occupations as risk factors for craniosynostosis in offspring. Epidemiology 6:306–310. https://doi.org/10.1097/00001648-199505000-00020 source
May combine two claims.
FindingcitationThe effect of maternal smoking on sCS risk varies with timing of cessation and number of cigarettes smoked per day, with highest risk in women smoking more than 15 cigarettes/day.
“The effect can vary depending on both the timing of maternal smoking cessation (e.g. in the first, second, or third trimester) and the number of cigarettes smoked per day (with the highest risk observed in women smoking more than 15 cigarettes/day) [69].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Honein MA, Rasmussen SA (2000) Further evidence for an association between maternal smoking and craniosynostosis. Teratology 62:145–146. https://doi.org/10.1002/1096-9926(200009)62:3%3C145::AID-TERA1%3E3.0.CO;2-7 source
May combine two claims.
Findingown dataMost included studies come from North America (34/97) and have 6501 (58.6%) of all sCS patients; Europe has 31/97 studies and 1356 (12.2%) patients; Asia and Oceania have 12/97 and 7/97 studies with 409/2426 (3.7% & 21.9%) sCS patients.
“Collectively, most of the studies come from North America (34/97) and have 6501 (58.6%) of all sCS patients in this systematic review; secondly, there is Europe with (31/97 studies) and 1356 (12.2%) patients, then Asia and Oceania (12/97 & 7/97 studies) with 409/2426 (3.7% & 21.9%) sCS patients.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationMaternal smoke is one of the first and most documented risk factors for CS, with OR 1.48-5.12 for sagittal suture fusion.
“Maternal smoke is one of the first and most documented risk factors for the insurgence of CS with OR 1.48–5.12 [15, 63, 69] for sagittal suture fusion.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [15] Källén K (1999) Maternal smoking and craniosynostosis. Teratology 60:146–150. https://doi.org/10.1002/(sici)1096-9926(199909)60:3%3C146::aid-tera10%3E3.3.co;2-v source
- cites [63] Farooq S, Morton J, Lloyd M, Krishna ST (2020) The influence of epigenetic factors in four pairs of twins with non-syndromic craniosynostosis. J Craniofac Surg 31:283–285. https://doi.org/10.1097/SCS.0000000000006064 source
- cites [69] Honein MA, Rasmussen SA (2000) Further evidence for an association between maternal smoking and craniosynostosis. Teratology 62:145–146. https://doi.org/10.1002/1096-9926(200009)62:3%3C145::AID-TERA1%3E3.0.CO;2-7 source
May combine two claims.
Findingown dataThe male predominance in sCS has been found consistently from 1980 to 2024 and despite population or region of birth.
“These data have been found consistently during the years (from 1980 to 2024) and despite the population or region of birth.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Findingnone givenThe scarce evidence of integrative studies simultaneously assessing genetic and environmental variables represents a major limitation in the current literature.
“However, the scarce evidence of integrative studies simultaneously assessing genetic and environmental variables represents a major limitation in the current literature.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningHeterogeneity across studies, differences in genetic testing methodologies, potential bias in exposure assessment, and limited availability of integrative analyses restrict definitive conclusions regarding the relative contribution of genetic and environmental factors.
“However, heterogeneity across studies, differences in genetic testing methodologies, potential bias in exposure assessment, and the limited availability of integrative analyses restrict definitive conclusions regarding the relative contribution of these factors.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA written protocol specifying the research question, population, exposures, inclusion/exclusion criteria, search strategy, and data extraction plan was established prior to data collection.
“A written protocol specifying the research question, population, exposures of interest (genetic variants and environmental/perinatal factors), inclusion and exclusion criteria, planned search strategy, and data extraction plan was established by the authors prior to the commencement of data collection.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAlthough more than 60 genes have been implicated in craniosynostosis overall, the genetic basis of isolated sagittal synostosis remains less clearly defined.
“Although more than 60 genes have been implicated in CS overall, including FGFR1–3, TWIST1, EFNB1, and ERF, the genetic basis of isolated sagittal synostosis remains less clearly defined [21].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Yilmaz E, Mihci E, Nur B et al (2019) Recent advances in craniosynostosis. Pediatr Neurol 99:7–15. https://doi.org/10.1016/j.pediatrneurol.2019.01.018 source
Classified as probably not a substantial claim.
Study design and conductown dataThe methodological quality of included studies was independently assessed by two reviewers using the Newcastle-Ottawa Scale (NOS).
“The methodological quality of included studies was independently assessed by two reviewers (V.DG. and D.D.T.) using the Newcastle-Ottawa Scale (NOS).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationsCS may not always represent a purely isolated developmental anomaly but can also arise as part of broader syndromic or metabolic conditions.
“The sCS may not always represent a purely isolated developmental anomaly but can also arise as part of broader syndromic or metabolic conditions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA variant in ALX4 was found associated with a moderate form of frontonasal dysplasia type 1 with minute parietal foramina.
“Particularly, ALX4 is involved in craniofacial development [62], anda variant in ALX4 was found associated with a moderate form of frontonasal dysplasia type 1 with minute parietal foramina [126].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [126] Altunoglu U, Satkin B, Uyguner ZO, Kayserili H (2014) Mild nasal clefting may be predictive for ALX4 heterozygotes. Am J Med Genet Part A 164:2054–2058 source
May combine two claims.
InterpretationreasoningsCS has a markedly heterogeneous genetic basis and is unlikely to be explained by a single dominant molecular mechanism.
“The available evidence indicates that sCS has a markedly heterogeneous genetic basis and is unlikely to be explained by a single dominant molecular mechanism.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenDiscrepancies between reviewers at either selection stage were resolved through discussion, and if consensus was not reached, a third senior reviewer adjudicated.
“Any discrepancies between reviewers at either stage were resolved through discussion, and if consensus was not reached, a third senior reviewer adjudicated (F. T.).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenData extraction was performed independently by two reviewers using a standardized form.
“Data extraction was performed independently by two reviewers (V.DG. and D.D.T.) using a standardized form.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDisagreements in data extraction were resolved through discussion and consensus (>80%).
“Disagreements were resolved through discussion and consensus (> 80%).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductreasoningCase reports and case series were not scored using the NOS; instead, they were narratively assessed and classified as inherently carrying a high risk of bias due to absence of a control group, small sample sizes, and limited generalizability.
“Case reports and case series were not scored using the NOS, as this instrument is not validated for these study designs; instead, they were narratively assessed and classified as inherently carrying a high risk of bias due to the absence of a control group, small sample sizes, and limited generalizability.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningGiven clinical and methodological heterogeneity across included studies, a narrative synthesis was performed rather than a quantitative meta-analysis.
“Given the clinical and methodological heterogeneity across the included studies, a narrative synthesis was performed rather than a quantitative meta-analysis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationGeographic location and place of birth have been associated with variation in CS risk, suggesting that contextual and environmental factors linked to where individuals are born and parents reside may contribute to disease susceptibility.
“Geographic location and place of birth have been associated with variation in CS risk, suggesting that contextual and environmental factors linked to where individuals are born, and parents reside may contribute to disease susceptibility.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAcross epidemiological studies of NCS, maternal smoking, micronutrient intake, fertility treatment, and exposure to metals emerge as high risk factors, suggesting that alterations in the intrauterine metabolic and endocrine milieu may influence suture patency during critical windows of craniofacial development.
“Across epidemiological studies of NCS, factors such as maternal smoking, micronutrient intake, fertility treatment, and exposure to metals emerge as high risk factors, suggesting that alterations in the intrauterine metabolic and endocrine milieu may influence suture patency during critical windows of craniofacial development.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThese birth-related factors are suggested to be correlated with intra-uterine compression of the foetus, which can lead to wrong mechanical stimuli for normal growth of the skull.
“These factors are suggested to be correlated with intra-uterine compression of the foetus, which ultimately can lead to wrong mechanical stimuli for the normal growth of the skull.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningThe effects of parental age can be explained by the increase of sperm and oocytes DNA damage and mutation with age, which then leads to birth defects.
“These effects can be explained by the increase of sperm and oocytes DNA damage and mutation with age, which then leads to birth defects.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningOverall, sCS exhibits a highly heterogeneous genetic structure, in which rare high-impact variants coexist with a multifactorial/oligogenic contribution.
“Overall, the evidence gathered confirmed that sCS exhibited a highly heterogeneous genetic structure, in which rare high impact variants coexisted with a multifactorial/oligogenic contribution.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThese exposures can alter FGFR2 expression by decreasing methylation in the FGFR2 regulatory region and enhancing access to the Sp1 transcription factor, leading to abnormal FGFR2 upregulation and premature osteogenic differentiation.
“These exposures can alter FGFR2 expression by decreasing methylation in the FGFR2 regulatory region and enhancing access to the Sp1 transcription factor, leading to abnormal FGFR2 upregulation and premature osteogenic differentiation [114].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [114] Weng Z, Xu C, Chen X et al (2024) Sp1-activated FGFR2 is involved in early-life exposure to nickel-induced craniosynostosis by regulating the ERK1/2 signaling pathway. Environ Int 184:108477. https://doi.org/10.1016/j.envint.2024.108477 source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe association between higher parental education and sCS may reflect differences in socioeconomic status, potentially leading to improved access to healthcare services and higher rates of diagnosis in families with higher educational attainment compared to lower-income groups.
“This association may reflect differences in socioeconomic status, potentially leading to improved access to healthcare services and, consequently, higher rates of diagnosis in families with higher educational attainment compared to lower-income groups.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe hypothesis that sCS arises from gene-environment interplay is consistent with evidence of shared heritability across syndromic CS and NCS and with models of cranial development emphasizing the integration of molecular signalling and biomechanical forces.
“This hypothesis is consistent with evidence of shared heritability across syndromic CS and NCS and with models of cranial development emphasizing the integration of molecular signalling and biomechanical forces.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe predominance of negative or heterogeneous genetic findings underscores the complexity of the condition and suggests that genetic susceptibility alone is often insufficient to drive disease onset.
“The predominance of negative or heterogeneous genetic findings underscores the complexity of the condition and suggests that genetic susceptibility alone is often insufficient to drive disease onset.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenCurrent evidence is limited by heterogeneity across studies, potential biases in exposure assessment, and a lack of integrative analyses combining genetic and environmental data.
“However, current evidence is limited by heterogeneity across studies, potential biases in exposure assessment, and a lack of integrative analyses combining genetic and environmental data.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningThe expanding use of molecular diagnostics is progressively improving our understanding of the genetic architecture of sCS and may help clarify the extent to which genetic predisposition contributes to disease development, either independently or through interaction with environmental factors.
“This expanding use of molecular diagnostics is progressively improving our understanding of the genetic architecture of sCS and may help clarify the extent to which genetic predisposition contributes to disease development, either independently or through interaction with environmental factors.”
Quote in the paperNot a substantial claim- Rests on an assumption: In recent years, there has been a growing trend toward the implementation of comprehensive genetic screening in patients with non-syndromic craniosynostosis.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenThe 26-year time frame covered by the selected studies provides a comprehensive overview of the existing evidence.
“The 26-year time frame covered by the selected studies provides a comprehensive overview of the existing evidence.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenRestricting the review to a clearly defined CS subtype such as sCS increased the homogeneity of the included studies.
“Moreover, restricting the review to a clearly defined CS subtype such as sCS increased the homogeneity of the included studies.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe included sSC sample size of more than 11,086 patients is a strength.
“The main strengths of this study include its stringent and transparent methodology which increases reproducibility and the included sSC sample size of more than 11,086 patients.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe main strengths of this study include its stringent and transparent methodology which increases reproducibility.
“The main strengths of this study include its stringent and transparent methodology which increases reproducibility and the included sSC sample size of more than 11,086 patients.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningUnderpowered studies may lead to unstable effect estimates and reduced ability to detect true associations.
“This may lead to unstable effect estimates and reduced ability to detect true associations.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationnone givenThe evidence synthesized in this review supports a multifactorial model for sCS, in which neither genetic nor environmental factors appear to act as individually deterministic drivers in the etiopathogenesis of sCS.
“In conclusion, the evidence synthesized in this review supports a multifactorial model for sCS, in which neither genetic nor environmental factors appear to act as individually deterministic drivers in the etiopathogenesis of sCS, supporting a model in which multiple components likely interact.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningTwin observations have been interpreted as consistent with a shared genetic susceptibility combined with non-shared environmental and/or stochastic factors, which may differentially perturb cranial signalling pathways and drive premature osteogenic differentiation in distinct sutures.
“These observations have been interpreted as consistent with a shared genetic susceptibility combined with non-shared environmental and/or stochastic factors, which may differentially perturb cranial signalling pathways and drive premature osteogenic differentiation in distinct sutures.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Study design and conductnone givenLimiting the literature search to the PubMed database only may have resulted in a limited number of relevant publications being overlooked, although this is not expected to have had a major impact on the study overall.
“Limiting the literature search to the PubMed database only may have resulted in a limited number of relevant publications being overlooked, although this is not expected to have had a major impact on the study overall.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The germline variants reported by included studies are correctly classified as pathogenic or likely pathogenic and are causally related to sCS.
“Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients”
“A pathogenic germline mutation was reported for 259 patients (12.6%) out of 2060 (75.9%) sequenced and genetically tested patients from 2636 identified patients with sCS.”
The paper relies on this without support.
The genetic testing methodologies used in the included studies would have detected pathogenic germline variants in key signalling pathways if present.
“most cases lack identifiable germline mutations in key signalling pathways”
“differences in genetic testing methodologies”
The paper relies on this without support.
The included studies are a representative and complete body of evidence on genetic and environmental determinants of sCS.
“Using the PubMed database in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, relevant studies addressing genetic and/or environmental determinants of sCS in paediatric patients were systematically reviewed.”
“A total of 1238 records were identified, of which 97 studies met inclusion criteria after full-text review.”
The paper relies on this without support.
sCS is a rare and heterogeneous condition.
“Overall, the available literature is characterized by a predominance of descriptive and observational study designs, reflecting the rarity and heterogeneity of the condition.”
The paper relies on this without support.
Thyroid hormones play a well-established role in skeletal development.
“Maternal thyroid disease has also been linked to an increased risk of CS, with reported ORs ranging from 1.3 to 2.11 [56, 93], consistent with the well-established role of thyroid hormones in skeletal development.”
The paper relies on this without support.
Reliance on parental self-report introduces recall bias for early pregnancy exposures such as diet, supplement use, smoking, and environmental factors.
“In addition, reliance on parental self-report introduces recall bias, particularly for early pregnancy exposures such as diet, supplement use, smoking, and environmental factors.”
The paper relies on this without support.
Monozygotic twins share nearly identical genetic backgrounds.
“Because monozygotic twins share (nearly) identical genetic backgrounds, reports of twin pairs in which both are affected by CS but with different sutures involved are particularly informative.”
The paper relies on this without support.
In recent years, there has been a growing trend toward the implementation of comprehensive genetic screening in patients with non-syndromic craniosynostosis.
“In recent years, there has been a growing trend toward the implementation of comprehensive genetic screening in patients with non-syndromic craniosynostosis, driven by advances in sequencing technologies and the increasing recognition of pathogenic variants in cases previously considered idiopathic.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Incorrect percentage of sagittal patients genetically tested
MajorThe stated 2060 genetically tested patients are 78.1% of the 2636 identified patients with sagittal craniosynostosis, not 75.9%.
Reported 75.9 · recomputed 78.14871
“A pathogenic germline mutation was reported for 259 patients (12.6%) out of 2060 (75.9%) sequenced and genetically tested patients from 2636 identified patients with sCS.”
TWIST1 has two chromosome locations in Table 5
MinorTable 5 locates TWIST1 at 11p11.2 in one row and 7p21.1 in another.
“| 1 | 11p11.2 | TWIST1 | Pathogenic SNV | c.439C>G | NM_000474 | Gln147Glu |”
“| 3 | 7p21.1 | TWIST1 | SNV | c.563C>T | NM_000474.2 | Ser188Leu |”
Conflicting counts of patients with reported germline variants
MinorThe abstract reports variants in 251 patients, whereas the study characteristics report pathogenic germline mutations in 259 patients.
“Germline genetic variants potentially associated with craniosynostosis were reported in 251 patients, accounting for 12.6% of genetically tested individuals with sCS.”
“A pathogenic germline mutation was reported for 259 patients (12.6%) out of 2060 (75.9%) sequenced and genetically tested patients from 2636 identified patients with sCS.”
AXIN2 has two chromosome locations in Table 5
MinorTable 5 assigns AXIN2 to both 8p11.23 and 17q24.1.
“| 1 | 8p11.23 | AXIN2 | SV | c.1045_1046delCT | NM_004655.3 | Lys349fs*24 |”
“| 1 | 17q24.1 | AXIN2 | SNV | c.1181G>A | rs200899695 | Arg394His |”
Included-study count changes from 97 to 96
MinorThe results say 97 records passed full-text review, but the subsequent description says data were extracted from 96 included publications.
“The 97 records passing full-text review included 25,877 patients, among whom 11,086 were diagnosed with sagittal synostosis (42.8%).”
“Data extracted from the 96 included publications are presented in Table 4.”
SMAD6 has two chromosome locations in Table 5
MinorTable 5 places SMAD6 variants at both 5q31.2 and 15q22.31.
“| 1 | 5q31.2 | SMAD6 | Damaging SNV | c.A916G | | Thr306Ala |”
“| 1 | 15q22.31 | SMAD6 | SNV | c.874+4A>G, | NM_005585.4 | |”
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283 · see citing works
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092 · cited 1× · see citing works
“Study selection was conducted in two stages by two independent reviewers (V. DG and D. D. T.) using Rayyan systematic review software [39]: stage 1, title, and abstract screening: All retrieved citations were independently screened by both reviewers using the prespecified eligibility criteria.”
Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., Moher, D., Tugwell, P., Welch, V., Kristjansson, E., et al. (2017) · BMJ · doi:10.1136/bmj.j4008 · Cited by 10,636 · cited 1× · see citing works
“AMSTAR 2 appraisal tool has been used to assess systematic review quality [37].”
Johnson, D., & Wilkie, A. O. M. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.235 · Cited by 499 · cited 3× · see citing works
“Current evidence is fragmented and often limited by small sample sizes or the investigation of isolated risk factors [10, 29, 31, 36].”
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495 · see citing works
A population‐based study of craniosynostosis in metropolitan Atlanta, 1989–2003
Boulet, S. L., Rasmussen, S. A., & Honein, M. A. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32208 · Cited by 370 · cited 6× · see citing works
“Craniosynostosis (CS) is a group of rare craniofacial disorders affecting approximately 1:2500 live births [1, 2].”
InfluentialPrevalence and Complications of Single-Gene and Chromosomal Disorders in Craniosynostosis
Wilkie, A. O. M., Byren, J. C., Hurst, J. A., Jayamohan, J., Johnson, D., Knight, S. J. L., Lester, T., Richards, P. G., Twigg, S. R. F., & Wall, S. A. (2010) · Pediatrics · doi:10.1542/peds.2009-3491 · Cited by 297 · see citing works
Jenkins, D., Seelow, D., Jehee, F. S., Perlyn, C. A., Alonso, L. G., Bueno, D. F., Donnai, D., Josifiova, D., Mathijssen, I. M. J., Morton, J. E. V., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/518047 · Cited by 276 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
A Genetic-Pathophysiological Framework for Craniosynostosis
Twigg, S. R. F., & Wilkie, A. O. M. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.07.006 · Cited by 276 · cited 1× · see citing works
“These include in utero mechanical constraints, maternal health conditions, medication exposure, and other prenatal risk factors [1, 2, 11, 22–25].”
Tamburrini, G., Caldarelli, M., Massimi, L., Santini, P., & Di Rocco, C. (2005) · Child's Nervous System · doi:10.1007/s00381-004-1117-x · Cited by 261 · see citing works
Self-citationEvolution in the frequency of nonsyndromic craniosynostosis: Clinical article
Di Rocco, F., Arnaud, E., & Renier, D. (2009) · Journal of Neurosurgery: Pediatrics · doi:10.3171/2009.3.peds08355 · Cited by 253 · see citing works
Reefhuis, J., & Honein, M. A. (2004) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20065 · Cited by 253 · see citing works
Johnson, D., Horsley, S. W., Moloney, D. M., Oldridge, M., Twigg, S. R. F., Walsh, S., Barrow, M., Njølstad, P. R., Kunz, J., Ashworth, G. J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302122 · Cited by 230 · see citing works
Long-term neuropsychological effects of sagittal craniosynostosis on child development
Magge, S. N., Westerveld, M., Pruzinsky, T., & Persing, J. A. (2002) · Journal of Craniofacial Surgery · doi:10.1097/00001665-200201000-00023 · Cited by 214 · see citing works
Craniosynostosis - Recognition, clinical characteristics, and treatment
Kajdic, N., Spazzapan, P., & Velnar, T. (2017) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2017.2083 · Cited by 213 · cited 2× · see citing works
“In contrast, non-syndromic CS (NCS) typically involves a single suture and represents approximately 70–75% of all cases [11, 12].”
Clinical genetics of craniosynostosis
Wilkie, A. O. M., Johnson, D., & Wall, S. A. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000542 · Cited by 204 · cited 1× · see citing works
“…account for approximately 25–30% of cases and are commonly associated with monogenic mutations in key osteogenic genes including FGFR1-3 ( Fibroblast Growth Factor Receptor 1–3 ), TWIST1 ( Twist Family BHLH Transcription Factor 1 ), EFNB1 ( Ephrin-B1 ), and ERF ( ETS2 Repressor Factor ) [7–10].”
Timberlake, A. T., Choi, J., Zaidi, S., Lu, Q., Nelson-Williams, C. J., Brooks, E. D., Bilgüvar, K., Tikhonova, I., Mane, S., Yang, J. F., et al. (2016) · eLife · doi:10.7554/elife.20125 · Cited by 195 · see citing works
Association between maternal age and birth defects of unknown etiology ― United States, 1997–2007
Gill, S. K., Broussard, C., Devine, O., Green, R. F., Rasmussen, S. A., Reefhuis, J., & Study, A. T. N. B. D. P. (2012) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23049 · Cited by 153 · see citing works
The Changing Epidemiologic Spectrum of Single-Suture Synostoses
Selber, J. C., Reid, R. R., Chike-Obi, C. J., Sutton, L. N., Zackai, E. H., McDonald‐McGinn, D. M., Sonnad, S. S., Whitáker, L. A., & Bartlett, S. P. P. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31817d548c · Cited by 147 · see citing works
Justice, C. M., Yagnik, G., Kim, Y., Peter, I., Jabs, E. W., Erazo, M., Ye, X., Ainehsazan, E., Shi, L., Cunningham, M. L., et al. (2012) · Nature Genetics · doi:10.1038/ng.2463 · Cited by 140 · cited 2× · see citing works
“…the BMP/SMAD pathway, particularly through SMAD6 , whose variants represent one of the most consistent findings in midline NCS [62]; importantly, their penetrance appears to be modified by common regulatory variation near BMP2 , supporting a two-locus model rather than a simple monogenic one [76].”
Genetic advances in craniosynostosis
Lattanzi, W., Barba, M., Di Pietro, L., & Boyadjiev, S. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38159 · Cited by 129 · cited 2× · see citing works
“Craniosynostosis (CS) is a group of rare craniofacial disorders affecting approximately 1:2500 live births [1, 2].”
Self-citationDiagnostic value of exome and whole genome sequencing in craniosynostosis
Miller, K. A., Twigg, S. R. F., McGowan, S. J., Phipps, J. M., Fenwick, A. L., Johnson, D., Wall, S. A., Noons, P., Rees, K. E. M., Tidey, E. A., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104215 · Cited by 122 · see citing works
Changing Epidemiology of Nonsyndromic Craniosynostosis and Revisiting the Risk Factors
Lee, H. Q., Hutson, J. M., Wray, A. C., Lo, P. A., Chong, D. K., Holmes, A. D., & Greensmith, A. L. (2012) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e318252d893 · Cited by 116 · cited 3× · see citing works
“At birth, there are some phenotypes that has been seen to correlate with sCS, from high weight at birth ≥ 4000 g (OR 1.61–2.91) [ 2, 82] to very low birth weight 2500 g (OR = 1.5–2.32) [ 29, 102]), also to breech presentation (OR = 2.39) [63, 102].”
InfluentialGreenwood, J., Flodman, P., Osann, K., Boyadjiev, S. A., & Kimonis, V. (2014) · Genetics in Medicine · doi:10.1038/gim.2013.134 · Cited by 113 · cited 4× · see citing works
“Both genetic predisposition and environmental influences contribute to NCS aetiology [12, 13].”
InfluentialCraniosynostosis and fetal exposure to sodium valproate
Lajeunie, E., Barcik, U., Thorne, J. A., Ghouzzi, V. E., Bourgeois, M., & Renier, D. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.5.0778 · Cited by 109 · see citing works
Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations
Seto, M. L., Hing, A. V., Chang, J., Hu, M., Kapp‐Simon, K. A., Patel, P. K., Burton, B. K., Kane, A. A., Smyth, M. D., Hopper, R., et al. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31630 · Cited by 108 · cited 2× · see citing works
“Mutations in the classical CS genes are relatively uncommon in apparently isolated sCS. Variants in TWIST1 , FGFR1 , and FGFR2 have been described, although each accounts for only a minor proportion of cases [62, 98, 120].”
InfluentialFetal constraint as a potential risk factor for craniosynostosis
Sanchez‐Lara, P. A., Carmichael, S. L., Graham, J. M., Lammer, E. J., Shaw, G. M., Ma, C., & Rasmussen, S. A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33246 · Cited by 106 · cited 6× · see citing works
“It has been reported also that fertility treatments correlate to an increased presence of only sagittal synostosis if there is a twin gestation OR 1.6 [29].”
InfluentialCopy-Number Variations Involving the IHH Locus Are Associated with Syndactyly and Craniosynostosis
Klopocki, E., Lohan, S., Brancati, F., Koll, R., Brehm, A., Seemann, P., Dathe, K., Stricker, S., Hecht, J., Bosse, K., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.006 · Cited by 104 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
Ruiz-Correa, S., Sze, R. W., Starr, J. R., Lin, H.-T. J., Speltz, M. L., Cunningham, M. L., & Hing, A. V. (2006) · The Cleft Palate-Craniofacial Journal · doi:10.1597/04-208.1 · Cited by 90 · see citing works
Maternal Thyroid Disease as a Risk Factor for Craniosynostosis
Rasmussen, S. A., Yazdy, M. M., Carmichael, S. L., Jamieson, D. J., Canfield, M. A., & Honein, M. A. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000270157.88896.76 · Cited by 81 · cited 5× · see citing works
“Other possible risks during gestation that has been found in this systematic review are pre-pregnancy obesity (BMI ≥ 30) [93, 96], pre-term gestation ( 37 weeks) OR = 1.7–2.41 ( n = 3) [29, 102]), number of previous births if two or more OR 1.29–1.39 (Lee 2012), if four or more the risks are been…”
InfluentialEvaluation and management of nonsyndromic craniosynostosis
Ursitti, F., Fadda, T., Papetti, L., Pagnoni, M., Nicita, F., Iannetti, G., & Spalice, A. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02299.x · Cited by 79 · cited 1× · see citing works
“Early fusion is generally associated with more severe deformities, whereas later fusion results in milder phenotypes [5].”
Mefford, H. C., Shafer, N., Antonacci, F., Tsai, J. M., Park, S. S., Hing, A. V., Rieder, M. J., Smyth, M. D., Speltz, M. L., Eichler, E. E., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33557 · Cited by 78 · cited 1× · see citing works
“…and microdu-plications, and CNVs involving regions that include genes such as FGF2 , SPRY1 , SEMA5A , FBLN2 , and TMEM43 support the concept that altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants [64, 85, 87, 115, 124].”
Rothenbuhler, A., Fadel, N., Debza, Y., Bacchetta, J., Diallo, M. T., Adamsbaum, C., Linglart, A., & Di Rocco, F. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3614 · Cited by 78 · cited 1× · see citing works
“This is particularly evident in PHEX-related X-linked hypophosphatemic rickets (XLHR), in which sagittal suture involvement appears strikingly frequent and, in some cohorts, nearly constant [43, 81, 95].”
Increased risk of craniosynostosis with maternal cigarette smoking during pregnancy
Alderman, B. W., Bradley, C. M., Greene, C. L., Fernbach, S. K., & Barón, A. E. (1994) · Teratology · doi:10.1002/tera.1420500103 · Cited by 71 · cited 1× · see citing works
“It occurs more frequently in males and is typically diagnosed in the neonatal period through clinical examination [15, 16]. sCS is characterized by an elongated and narrow skull (scaphocephaly), with frontal and occipital bossing and reduced biparietal width, without significant facial or skull…”
Genetic and Environmental Risk Factors for Sagittal Craniosynostosis
Zeiger, J. S., Beaty, T. H., Hetmanski, J. B., Wang, H., Scott, A. F., Kasch, L., Raymond, G., Jabs, E. W., & VanderKolk, C. (2002) · Journal of Craniofacial Surgery · doi:10.1097/00001665-200209000-00002 · Cited by 66 · cited 3× · see citing works
“…have identified several demographic and environmental associations, such as male sex, advanced maternal age, and specific prenatal exposures including maternal smoking, hypoxia-related conditions, sodium valproate, retinoic acid, antidepressants, and assisted reproductive technologies [15, 26–35].”
InfluentialRecent Advances in Craniosynostosis
Yilmaz, E., Mihci, E., Nur, B., Alper, Ö. M., & Taçoy, Ş. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.01.018 · Cited by 63 · cited 1× · see citing works
“Although more than 60 genes have been implicated in CS overall, including FGFR1–3 , TWIST1 , EFNB1 , and ERF , the genetic basis of isolated sagittal synostosis remains less clearly defined [21].”
Craniosynostosis and maternal smoking
Carmichael, S. L., Ma, C., Rasmussen, S. A., Honein, M. A., Lammer, E. J., & Shaw, G. M. (2008) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20426 · Cited by 62 · cited 1× · see citing works
“Current evidence is fragmented and often limited by small sample sizes or the investigation of isolated risk factors [10, 29, 31, 36].”
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations
Kratz, C. P., Zampino, G., Kriek, M., Kant, S. G., Leoni, C., Pantaleoni, F., Oudesluys‐Murphy, A. M., Rocco, C. D., Kloska, S. P., Tartaglia, M., et al. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32786 · Cited by 61 · see citing works
Genetic basis of single-suture synostoses: genes, chromosomes and clinical implications
Lattanzi, W., Bukvić, N., Barba, M., Tamburrini, G., Bernardini, C., Michetti, F., & Rocco, C. D. (2012) · Child s Nervous System · doi:10.1007/s00381-012-1781-1 · Cited by 61 · cited 1× · see citing works
“Depending on the suture involved, CS results in characteristic skull shape abnormalities and is classified as scaphocephaly (sagittal synostosis), trigonocephaly (metopic synostosis), brachycephaly (bicoronal synostosis), or anterior/posterior plagiocephaly (unicoronal or lambdoid synostosis) [3–6].”
Self-citationAntiepileptic drugs in women with epilepsy during pregnancy
Gedzelman, E., & Meador, K. J. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611433192 · Cited by 57 · cited 1× · see citing works
“Current evidence is fragmented and often limited by small sample sizes or the investigation of isolated risk factors [10, 29, 31, 36].”
Fertility Treatments and Craniosynostosis: California, Georgia, and Iowa, 1993–1997
Reefhuis, J., Honein, M. A., Shaw, G. M., & Romitti, P. A. (2003) · Pediatrics · doi:10.1542/peds.111.s1.1163 · Cited by 56 · see citing works
Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases
Currarino, G. (2007) · Pediatric Radiology · doi:10.1007/s00247-007-0503-4 · Cited by 52 · see citing works
James, A. W., Levi, B., Xu, Y., Carre, A. L., & Longaker, M. T. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181d62980 · Cited by 52 · see citing works
Differential Expression of Extracellular Matrix-Mediated Pathways in Single-Suture Craniosynostosis
Stamper, B. D., Park, S. S., Beyer, R. P., Bammler, T. K., Farin, F. M., Mecham, B., & Cunningham, M. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026557 · Cited by 49 · see citing works
Ueda, K., Yaoita, M., Niihori, T., Aoki, Y., & Okamoto, N. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38337 · Cited by 46 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
Clarke, C. M., Fok, V. T., Gustafson, J. A., Smyth, M. D., Timms, A. E., Frazar, C. D., Smith, J. D., Birgfeld, C. B., Lee, A., Ellenbogen, R. G., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38540 · Cited by 44 · cited 4× · see citing works
“%) lack mutations in key signalling pathways, further supporting a prominent role for non-genetic contributions [3, 25, 42].”
InfluentialCraniosynostosis and nutrient intake during pregnancy
Carmichael, S. L., Rasmussen, S. A., Lammer, E. J., Ma, C., Shaw, G. M., & Study, A. T. N. B. D. P. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20717 · Cited by 42 · cited 1× · see citing works
“Conversely, intake of specific micronutrients has been associated with a reduced risk of sCS, including riboflavin (OR = 0.5), vitamin B6 (OR = 0.4), vitamin E (OR = 0.6), and vitamin C (OR = 0.7) [55].”
InfluentialLee, E., Le, T., Zhu, Y., Elakis, G., Turner, A., Lo, W., Venselaar, H., Verrenkamp, C.-A., Snow, N., Mowat, D. R., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.214 · Cited by 41 · see citing works
Self-citationALX4 gain-of-function mutations in nonsyndromic craniosynostosis
Yagnik, G., Ghuman, A., Kim, S., Stevens, C., Kimonis, V. E., Stoler, J. M., Sanchez-Lara, P. A., Bernstein, J. A., Naydenov, C. L., Drissi, H., et al. (2012) · Human Mutation · doi:10.1002/humu.22166 · Cited by 41 · see citing works
PARENTAL OCCUPATIONS AS RISK FACTORS FOR CRANIOSYNOSTOSIS IN OFFSPRING
Bradley, C. M., Alderman, B. W., Williams, M. A., Checkoway, H., Fernbach, S. K., Greene, C., Bigelow, P. L., & Reif, J. S. (1995) · Epidemiology · doi:10.1097/00001648-199505000-00020 · Cited by 38 · cited 2× · see citing works
“In this study, paternal employment as mechanics/repairmen was associated with increased odds across multiple suture types (OR range: 1.8–3.0), whereas no association was observed for sagittal synostosis among fathers working in agriculture/forestry (OR = 0.9) [52].”
InfluentialIGF1R variants associated with isolated single suture craniosynostosis
Cunningham, M. L., Horst, J. A., Rieder, M. J., Hing, A. V., Stanaway, I. B., Park, S. S., Samudrala, R., & Speltz, M. L. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33781 · Cited by 38 · cited 1× · see citing works
“Likewise, rare variants in ALX4 and IGF1R support a contribution of genes involved in osteoblast differentiation and suture growth [59, 62119 Particularly, ALX4 is involved in craniofacial development [62], anda variant in ALX4 was found associated with a moderate form of frontonasal dysplasia type…”
FGF9 mutation causes craniosynostosis along with multiple synostoses
Rodriguez‐Zabala, M., Aza‐Carmona, M., Rivera-Pedroza, C. I., Belinchón, A., Guerrero‐Zapata, I., Barraza‐García, J., Vallespín, E., Lu, M., del Pozo, Á., Glucksman, M., et al. (2017) · Human Mutation · doi:10.1002/humu.23292 · Cited by 38 · see citing works
Intracranial volume measurement of sagittal craniosynostosis
Anderson, P. J., Netherway, D. J., McGlaughlin, K., & David, D. J. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.07.001 · Cited by 37 · cited 1× · see citing works
“In contrast, synonymous or common variants of FGFR3 have not shown clear pathogenic relevance, emphasizing the need to distinguish true disease-associated findings from background polymorphisms [23, 42].”
FG syndrome: Report of three new families with linkage to xq12-q22.1
Graham, J. M., Tackels, D., Dibbern, K. M., Superneau, D. W., Rogers, C. R., Corning, K., & Schwartz, C. E. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19981102)80:2 · Cited by 36 · see citing works
Never again joy without sorrow: The effect on parents of a child with ataxia-telangiectasia
Fanos, J. H., & Mackintosh, M. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19991222)87:5 · Cited by 35 · see citing works
Tolchin, D., Yeager, J. P., Prasad, P., Dorrani, N., Russi, A. S., Martínez-Agosto, J. A., Haseeb, A., Angelozzi, M., Santen, G. W. E., Ruivenkamp, C. A. L., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.04.015 · Cited by 34 · see citing works
Familial scaphocephaly syndrome caused by a novel mutation in the FGFR2 tyrosine kinase domain
McGillivray, G., Savarirayan, R., Cox, T. C., Stojkoski, C., McNeil, R., Bankier, A., Bateman, J. F., Roscioli, T., Gardner, R. J. M., & Lamandé, S. R. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027888 · Cited by 34 · cited 2× · see citing works
“The majority of the studies studied the odds ratio of male occurring CS with an OR ranging from 1.46 to 4.5 (with geometric mean of ~ 2.7) [2, 3, 15, 26, 50, 53, 74, 80, 82, 86, 96–98, 102, 103, 117].”
InfluentialTWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation
Fan, X., Waardenberg, A. J., Demuth, M., Osteil, P., Sun, J. Q. J., Loebel, D. A. F., Graham, M., Tam, P. P. L., & Fossat, N. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00663-19 · Cited by 33 · see citing works
Timberlake, A. T., Jin, S. C., Nelson-Williams, C. J., Wu, R. T., Furey, C. G., Islam, B., Haider, S. M., Loring, E. C., Galm, A., Steinbacher, D. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902041116 · Cited by 33 · see citing works
Mutation Screening of Candidate Genes in Patients with Nonsyndromic Sagittal Craniosynostosis
Ye, X., Guilmatre, A., Reva, B., Peter, I., Heuzé, Y., Richtsmeier, J. T., Fox, D. J., Goedken, R. J., Jabs, E. W., & Romitti, P. A. (2016) · Plastic and Reconstructive Surgery · doi:10.1097/01.prs.0000479978.75545.ee · Cited by 33 · cited 1× · see citing works
“Mutations in the classical CS genes are relatively uncommon in apparently isolated sCS. Variants in TWIST1 , FGFR1 , and FGFR2 have been described, although each accounts for only a minor proportion of cases [62, 98, 120].”
Craniosynostosis and risk factors related to thyroid dysfunction
Carmichael, S. L., Ma, C., Rasmussen, S. A., Cunningham, M. L., Browne, M. L., Dosiou, C., Lammer, E. J., & Shaw, G. M. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36953 · Cited by 32 · cited 4× · see citing works
“Maternal alcohol consumption has been associated with odds ratios close to unity (OR ~ 0.8–1.0) for sCS [56, 65], but this does not imply a protective effect and does not modify existing recommendations to abstain from alcohol during pregnancy.”
InfluentialO'Brien, J. L., Langlois, P. H., Lawson, C. C., Scheuerle, A., Rocheleau, C. M., Waters, M. A., Symanski, E., Romitti, P. A., Agopian, A. J., Lupo, P. J., et al. (2016) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.23389 · Cited by 31 · cited 1× · see citing works
“Another important factor that can influence skull growth and correct bone differentiation is maternal occupation, which can increase the exposure of metals [114, 118] and polycyclic aromatic hydrocarbons (PAHs) to the foetus [89].”
Di Rocco, F., Gleizal, A., Szathmari, A., Beuriat, P. A., Paulus, C., & Mottolese, C. (2019) · Neurochirurgie · doi:10.1016/j.neuchi.2019.09.011 · Cited by 30 · cited 3× · see citing works
“The sagittal suture does not fuse according to an all-or-nothing mechanism; rather, different segments of the suture may be variably involved, resulting in distinct morphological patterns largely explained by compensatory growth mechanisms, as described by Virchow’s law [14, 17–20].”
Isolation of differentially expressed genes from wild‐type and <i>Twist</i> mutant mouse limb buds
Loebel, D. A. F., O'Rourke, M. P., Steiner, K. A., Banyer, J., & Tam, P. P. L. (2002) · genesis · doi:10.1002/gene.10091 · Cited by 29 · cited 1× · see citing works
“ALX4 may be a potential target of TWIST1 or even TCF12 , both of which are required for calvarial development and suture closure [127, 128].”
Frank-ter Haar syndrome associated with sagittal craniosynostosis and raised intracranial pressure
Bendon, C. L., Fenwick, A. L., Hurst, J. A., Nürnberg, G., Nürnberg, P., Wall, S. A., Wilkie, A. O., & Johnson, D. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-104 · Cited by 28 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Osteoblast differentiation profiles define sex specific gene expression patterns in craniosynostosis
Park, S. S., Beyer, R. P., Smyth, M. D., Clarke, C. M., Timms, A. E., Bammler, T. K., Stamper, B. D., Mecham, B. H., Gustafson, J. A., & Cunningham, M. L. (2015) · Bone · doi:10.1016/j.bone.2015.03.001 · Cited by 27 · cited 1× · see citing works
“A possible explanation of this effect has been linked to possible sex-specific transcriptional factor that may alter osteoblasts differentiation signal mainly on males, while sCS occurrence in females have different genetic risk profiles [91].”
Serum nickel is associated with craniosynostosis risk: Evidence from humans and mice
Xu, C., Xu, J., Zhang, X., Xu, S., Liu, Q., Weng, Z., & Gu, A. (2020) · Environment International · doi:10.1016/j.envint.2020.106289 · Cited by 27 · cited 1× · see citing works
“The majority of the studies studied the odds ratio of male occurring CS with an OR ranging from 1.46 to 4.5 (with geometric mean of ~ 2.7) [2, 3, 15, 26, 50, 53, 74, 80, 82, 86, 96–98, 102, 103, 117].”
InfluentialRisk Factors Associated with Craniosynostosis: A Case Control Study
Ardalan, M., Rafati, A., Nejat, F., Farazmand, B., Majed, M., & Khashab, M. E. (2012) · Pediatric Neurosurgery · doi:10.1159/000346261 · Cited by 26 · cited 1× · see citing works
“…have identified several demographic and environmental associations, such as male sex, advanced maternal age, and specific prenatal exposures including maternal smoking, hypoxia-related conditions, sodium valproate, retinoic acid, antidepressants, and assisted reproductive technologies [15, 26–35].”
Molecular Diagnosis of Craniosynostosis Using Targeted Next-Generation Sequencing
Yoon, J. G., Hahn, H. M., Choi, S., Kim, S., Aum, S., Yu, J. W., Park, E.-K., Shim, K., Lee, M. G., & Kim, Y. O. (2019) · Neurosurgery · doi:10.1093/neuros/nyz470 · Cited by 26 · cited 1× · see citing works
“At the same time, Clarke et al. [25], Yoon et al. [123], and Sewda et al. [99] described numerous rare variants and variants of uncertain significance in genes including FLNA , KMT2D , RECQL4 , HUWE1 , IDUA , IL11RA , MEGF8 , FBN1 , NOTCH1/2 , ALPL , BMPER , and FREM1.”
Timberlake, A. T., McGee, S., Allington, G., Kiziltug, E., Wolfe, E. M., Stiegler, A. L., Boggon, T. J., Sanyoura, M., Morrow, M. M., Wenger, T. L., et al. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.017 · Cited by 26 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Cuellar, A., Bala, K., Di Pietro, L., Barba, M., Yagnik, G., Liu, J. L., Stevens, C., Hur, D. J., Ingersoll, R. G., Justice, C. M., et al. (2020) · Bone · doi:10.1016/j.bone.2020.115395 · Cited by 24 · cited 1× · see citing works
“Similarly, increasing evidence implicates WNT/β-catenin signalling through AXIN1, AXIN2, and RUNX2 , suggesting that dysregulated osteoblast differentiation may be a recurrent biological mechanism in sCS [58, 105, 118, 121].”
Self-citationIsolated Sagittal Craniosynostosis: A Comprehensive Review
Spazzapan, P., & Velnar, T. (2024) · Diagnostics · doi:10.3390/diagnostics14040435 · Cited by 24 · cited 3× · see citing works
“Among NCS, sagittal CS (sCS) is the most common form, accounting for 40–60% of all CS cases, with an estimated incidence of 1:5000 live births [14].”
Anderson, P. J., Cox, T. C., Roscioli, T., Elakis, G., Smithers, L., David, D. J., & Powell, B. (2007) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31802d6e76 · Cited by 23 · cited 2× · see citing works
“In contrast, synonymous or common variants of FGFR3 have not shown clear pathogenic relevance, emphasizing the need to distinguish true disease-associated findings from background polymorphisms [23, 42].”
Risk factors and time trends for isolated craniosynostosis
Schraw, J. M., Woodhouse, J. P., Langlois, P. H., Canfield, M. A., Scheuerle, A. E., Agopian, A. J., Benjamin, R. H., & Lupo, P. J. (2021) · Birth Defects Research · doi:10.1002/bdr2.1824 · Cited by 22 · cited 3× · see citing works
“Several studies consistently report a higher prevalence among individuals of white race [29, 93], whereas lower risks have been observed in black (OR = 0.2), Hispanic (OR = 0.4), and other racial or ethnic groups (OR = 0.6) [56, 96].”
InfluentialLin‐Gettig syndrome: Craniosynostosis expands the spectrum of the <i>KAT6B</i> related disorders
Bashir, R. A., Dixit, A., Goedhart, C., Parboosingh, J. S., Innes, A. M., Care for Rare Canada Consortium, Ferreira, P., Hasan, S. U., & Au, P. B. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38355 · Cited by 21 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Sharma, V. P., Wall, S. A., Lord, H., Lester, T., & Wilkie, A. O. M. (2012) · The Cleft Palate Craniofacial Journal · doi:10.1597/11-185 · Cited by 20 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Justice, C. M., Kim, J., Kim, S., Kim, K., Yagnik, G., Cuellar, A., Carrington, B., Lu, C., Sood, R. B., Boyadjiev, S. A., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38392 · Cited by 19 · see citing works
Barba, M., Di Pietro, L., Massimi, L., Geloso, M. C., Frassanito, P., Caldarelli, M., Michetti, F., Della Longa, S., Romitti, P. A., Di Rocco, C., et al. (2018) · Bone · doi:10.1016/j.bone.2018.04.013 · Cited by 19 · cited 1× · see citing works
“This is further reinforced by the identification of susceptibility loci near BMP2 and within BBS9 , as well as functional evidence implicating ciliogenesis and primary cilium biology in sagittal suture homeostasis [44, 76].”
Self-citationStudy of environmental and genetic factors in children with craniosynostosis: A case-control study
Barik, M., Bajpai, M., Das, R. R., & Panda, S. (2013) · Journal of Pediatric Neurosciences · doi:10.4103/1817-1745.117833 · Cited by 18 · see citing works
Scalp fibroblasts have a shared expression profile in monogenic craniosynostosis
Bochukova, E. G., Soneji, S., Wall, S. A., & Wilkie, A. O. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.069617 · Cited by 18 · see citing works
Mild nasal clefting may be predictive for <i>ALX4</i> heterozygotes
Altunoglu, U., Satkın, B., Uyguner, Z. O., & Kayserili, H. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36578 · Cited by 18 · cited 1× · see citing works
“…support a contribution of genes involved in osteoblast differentiation and suture growth [59, 62119 Particularly, ALX4 is involved in craniofacial development [62], anda variant in ALX4 was found associated with a moderate form of frontonasal dysplasia type 1 with minute parietal foramina [126].”
Nonsyndromic craniosynostosis: novel coding variants
Sewda, A., White, S. R., Erazo, M., Hao, K., García‐Fructuoso, G., Fernández-Rodriguez, I., Heuzé, Y., Richtsmeier, J. T., Romitti, P. A., Reva, B. A., et al. (2019) · Pediatric Research · doi:10.1038/s41390-019-0274-2 · Cited by 18 · cited 1× · see citing works
“At the same time, Clarke et al. [25], Yoon et al. [123], and Sewda et al. [99] described numerous rare variants and variants of uncertain significance in genes including FLNA , KMT2D , RECQL4 , HUWE1 , IDUA , IL11RA , MEGF8 , FBN1 , NOTCH1/2 , ALPL , BMPER , and FREM1.”
Körberg, I., Nowinski, D., Bondeson, M.-L., Melin, M., Kölby, L., & Stattin, E.-L. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-01015-z · Cited by 18 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Clinical interest of molecular study in cases of isolated midline craniosynostosis
Di Rocco, F., Rossi, M., Verlut, I., Szathmari, A., Beuriat, P. A., Chatron, N., Chauvel-Picard, J., Mottolese, C., Monin, P., Vinchon, M., et al. (2023) · European Journal of Human Genetics · doi:10.1038/s41431-023-01295-y · Cited by 18 · cited 3× · see citing works
“Mutations in the classical CS genes are relatively uncommon in apparently isolated sCS. Variants in TWIST1 , FGFR1 , and FGFR2 have been described, although each accounts for only a minor proportion of cases [62, 98, 120].”
A novel <i>AXIN2</i> gene mutation in sagittal synostosis
Yilmaz, E., Mihci, E., Guzel Nur, B., & Alper, O. M. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40373 · Cited by 17 · cited 1× · see citing works
“Similarly, increasing evidence implicates WNT/β-catenin signalling through AXIN1, AXIN2, and RUNX2 , suggesting that dysregulated osteoblast differentiation may be a recurrent biological mechanism in sCS [58, 105, 118, 121].”
Accogli, A., Pacetti, M., Fiaschi, P., Pavanello, M., Piatelli, G., Nuzzi, D., Baldi, M., Tassano, E., Severino, M., Allegri, A. E. M., et al. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36933 · Cited by 16 · see citing works
Wentz, E., Vujic, M., Kärrstedt, E.-L., Erlandsson, A., & Gillberg, C. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-013-0455-1 · Cited by 16 · cited 1× · see citing works
“…and microdu-plications, and CNVs involving regions that include genes such as FGF2 , SPRY1 , SEMA5A , FBLN2 , and TMEM43 support the concept that altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants [64, 85, 87, 115, 124].”
Clinical and genetic characteristics of craniosynostosis in Hungary
Bessenyei, B., Nagy, A., Szakszon, K., Mokánszki, A., Balogh, E., Ujfalusi, A., Tihanyi, M., Novák, L., Bognár, L., & Oláh, É. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37298 · Cited by 16 · cited 2× · see citing works
“…pre-pregnancy obesity (BMI ≥ 30) [93, 96], pre-term gestation ( 37 weeks) OR = 1.7–2.41 ( n = 3) [29, 102]), number of previous births if two or more OR 1.29–1.39 (Lee 2012), if four or more the risks are been found to increase with a OR = 2.0 [15, 93], or twin gestation OR 2.1–3.89 [2 , 29, 50].”
InfluentialFurther delineation of putative <i>ACTB</i> loss‐of‐function variants: A 4‐patient series
Baumann, M., Beaver, E. M., Palomares‐Bralo, M., Santos‐Simarro, F., Holzer, P., Povysil, G., Müller, T., Valovka, T., & Janecke, A. R. (2020) · Human Mutation · doi:10.1002/humu.23970 · Cited by 16 · see citing works
Clinical and Genetic Characterization of Craniosynostosis in Saudi Arabia
Alghamdi, M., Alhumsi, T. R., Altweijri, I., Alkhamis, W. H., Barasain, O., Cardona-Londoño, K. J., Ramakrishnan, R., Guzmán-Vega, F. J., Arold, S. T., Ali, G., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.582816 · Cited by 15 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Tønne, E., Due‐Tønnessen, B. J., Vigeland, M. D., Amundsen, S. S., Ribarska, T., Åsten, P. M., Sheng, Y., Helseth, E., Gilfillan, G. D., Mero, I., et al. (2022) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62663 · Cited by 15 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
RASopathy in Patients With Isolated Sagittal Synostosis
Davis, A. A., Zuccoli, G., Haredy, M. M., Losee, J., Pollack, I. F., Madan-Khetarpal, S., Goldstein, J. A., & Nischal, K. K. (2019) · Global Pediatric Health · doi:10.1177/2333794x19846774 · Cited by 13 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
Hereditary hypophosphatemic rickets and craniosynostosis
Arenas, M. A., Jaimovich, S., Perez Garrido, N., del Pino, M., Viterbo, G., Marino, R., & Fano, V. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0042 · Cited by 12 · cited 1× · see citing works
“This is particularly evident in PHEX-related X-linked hypophosphatemic rickets (XLHR), in which sagittal suture involvement appears strikingly frequent and, in some cohorts, nearly constant [43, 81, 95].”
Mutation analysis of <i>FGFR1‐3</i> in 11 Japanese patients with syndromic craniosynostoses
Ohishi, A., Nishimura, G., Kato, F., Ono, H., Maruwaka, K., Ago, M., Suzumura, H., Hirose, E., Uchida, Y., Fukami, M., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37992 · Cited by 11 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Fontaine-farriaux craniosynostosis: Second report in the literature
Priolo, M., Toni, T. D., Baffico, M., Cama, A., Seri, M., Cusano, R., Costabello, L., Fondelli, P., Capra, V., Silengo, M., et al. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010501)100:3 · Cited by 10 · see citing works
Barroso, E., Berges‐Soria, J., Benito‐Sanz, S., Rivera‐Pedroza, C. I., Ballesta‐Martínez, M. J., López‐González, V., Guillen‐Navarro, E., & Heath, K. E. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36811 · Cited by 10 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
Is Isolated Sagittal Synostosis an Isolated Condition?
Butzelaar, L., Breugem, C. C., Hanlo, P., & Mink van der Molen, A. B. (2009) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e31819b971a · Cited by 10 · cited 1× · see citing works
“The majority of the studies studied the odds ratio of male occurring CS with an OR ranging from 1.46 to 4.5 (with geometric mean of ~ 2.7) [2, 3, 15, 26, 50, 53, 74, 80, 82, 86, 96–98, 102, 103, 117].”
InfluentialThe Influence of Epigenetic Factors in Four Pairs of Twins With Non-Syndromic Craniosynostosis
Farooq, S., Morton, J., Lloyd, M., & Krishna, S. T. (2020) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000006064 · Cited by 10 · cited 3× · see citing works
“Maternal smoke is one of the first and most documented risk factors for the insurgence of CS with OR 1.48–5.12 [15, 63, 69] for sagittal suture fusion.”
InfluentialCalpena, E., Wurmser, M., McGowan, S. J., Atique, R., Bertola, D. R., Cunningham, M. L., Gustafson, J. A., Johnson, D., Morton, J. E. V., Passos‐Bueno, M. R., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107459 · Cited by 10 · see citing works
Xu, Y., Sun, S., Li, N., Yu, T., Wang, X., Wang, J., & Bao, N. (2017) · Gene · doi:10.1016/j.gene.2017.10.041 · Cited by 9 · see citing works
Epidemiology of Hospital Admissions for Craniosynostosis in Australia: A Population-Based Study
Junaid, M., Slack-Smith, L., Wong, K., Baynam, G., Calache, H., Hewitt, T., & Leonard, H. (2023) · The Cleft Palate Craniofacial Journal · doi:10.1177/10556656221074215 · Cited by 9 · see citing works
Eight patients with Williams syndrome and craniosynostosis
Ueda, K., Yamada, J., Takemoto, O., et al. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.05.002 · Cited by 8 · see citing works
Lee, K. S., & Lee, B. L. (2019) · Child's Nervous System · doi:10.1007/s00381-018-04042-7 · Cited by 8 · cited 1× · see citing works
“This is particularly evident in PHEX-related X-linked hypophosphatemic rickets (XLHR), in which sagittal suture involvement appears strikingly frequent and, in some cohorts, nearly constant [43, 81, 95].”
Sharova, M., Markova, T., Sumina, M., Petukhova, M., Bulakh, M., Ryzhkova, O., Nagornova, T., Ionova, S., Marakhonov, A., Dadali, E., et al. (2023) · Genes · doi:10.3390/genes14081553 · Cited by 8 · see citing works
Non-syndromic single-suture craniosynostosis in triplets
Chesler, D., Bram, R., Antwi, P., Timberlake, A. T., DiLuna, M. L., & Kahle, K. T. (2018) · Child s Nervous System · doi:10.1007/s00381-018-3754-5 · Cited by 7 · see citing works
Passos‐Bueno, M. R., Armelin‐Correa, L., Alonso, L. G., Neustein, I., Sertie, A. L., Abe, K. T., Pavanello, R. C. M., Elkis, L. C., & Koiffmann, C. P. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10752 · Cited by 5 · see citing works
Ittleman, B. R., Mckissick, J., Bosanko, K. A., Öcal, E., Golinko, M. S., & Zárate, Y. A. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38532 · Cited by 5 · see citing works
Introduction au rapport sur les craniosténoses
Di Rocco, F., & Zerah, M. (2019) · Neurochirurgie · doi:10.1016/j.neuchi.2019.10.001 · Cited by 5 · cited 2× · see citing works
“The sagittal suture does not fuse according to an all-or-nothing mechanism; rather, different segments of the suture may be variably involved, resulting in distinct morphological patterns largely explained by compensatory growth mechanisms, as described by Virchow’s law [14, 17–20].”
Weng, Z., Xu, C., Chen, X., Yan, Q., Fu, Z., Jiao, J., Xu, J., Liu, Q., Wang, D., Liang, J., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108477 · Cited by 5 · see citing works
Townes-Brocks syndrome with craniosynostosis in two siblings
Lugli, L., Rossi, C., Ceccarelli, P. L., Calabrese, O., Bedetti, L., Miselli, F., Bianchini, M. A., Iughetti, L., & Berardi, A. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104642 · Cited by 5 · cited 1× · see citing works
“…variants in genes such as FGFR2 , TCF12 , ERF , KAT6B , ACTB , SH3PXD2B , SALL1 , IFT140 , SON , CASK , FOXP2 , EXTL3 , and SOX6 have often been identified in patients with additional dysmorphic, skeletal, neurodevel-opmental, or systemic disorders [41, 47–49, 78, 84, 86, 90, 100, 101, 108–110].”
Fernández-Jaén, A., Fernández-Perrone, A. L., Fernández-Mayoralas, D. M., Calleja-Pérez, B., Sánchez-Hombre, M. D. C., Fernández, E. C., & López-Martín, S. (2014) · Child's Nervous System · doi:10.1007/s00381-014-2474-8 · Cited by 4 · cited 1× · see citing works
“…and microdu-plications, and CNVs involving regions that include genes such as FGF2 , SPRY1 , SEMA5A , FBLN2 , and TMEM43 support the concept that altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants [64, 85, 87, 115, 124].”
Novel chromosomal microduplications associated with dolichocephaly craniosynostosis: A case report
Yu, D., Li, S., Liu, Q., & Zhang, K. (2017) · Medicine · doi:10.1097/md.0000000000008729 · Cited by 4 · see citing works
Xu, J., Yan, Q., Song, C., Liang, J., Zhao, L., Zhang, X., Weng, Z., Xu, C., Liu, Q., Xu, S., et al. (2021) · Hereditas · doi:10.1186/s41065-021-00182-0 · Cited by 4 · cited 3× · see citing works
“Another important factor that can influence skull growth and correct bone differentiation is maternal occupation, which can increase the exposure of metals [114, 118] and polycyclic aromatic hydrocarbons (PAHs) to the foetus [89].”
De novo ALX4 variant detected in child with non-syndromic craniosynostosis
Fonteles, C. S. R., Finnell, R. H., Lei, Y., Zurita-Jimenez, M. E., Monteiro, A. J., George, T., & Harshbarger, R. J. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2021e11396 · Cited by 4 · see citing works
Monozygotic twins presenting with isolated sagittal and bicoronal synostosis, respectively
Hove, H. D., Dunø, M., Larsen, P., et al. (2016) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000112 · Cited by 3 · see citing works
Maldžienė, Ž., Bulanovaitė, E., Aleksiūnienė, B., Utkus, A., & Preiksaitiene, E. (2019) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000285 · Cited by 3 · cited 1× · see citing works
“…and microdu-plications, and CNVs involving regions that include genes such as FGF2 , SPRY1 , SEMA5A , FBLN2 , and TMEM43 support the concept that altered gene dosage and disrupted regulation can contribute to sCS even in the absence of pathogenic coding variants [64, 85, 87, 115, 124].”
Gayden, T., Crevier‐Sorbo, G., Jawhar, W., Saint‐Martin, C., Eveleigh, R. J. M., Gilardino, M. S., Anastasio, N., Trakadis, Y. J., Bassenden, A. V., Berghuis, A. M., et al. (2023) · Journal of Neurosurgery Pediatrics · doi:10.3171/2023.1.peds22287 · Cited by 3 · see citing works
AXIN1 mutations in nonsyndromic craniosynostosis
Timberlake, A. T., Hemal, K., Gustafson, J. A., Hao, L. T., Valenzuela, I., Slavotinek, A., Cunningham, M. L., Kahle, K. T., Lifton, R. P., & Persing, J. A. (2024) · Journal of Neurosurgery: Pediatrics · doi:10.3171/2024.5.peds24115 · Cited by 3 · see citing works
Transcriptomic Signatures of Single-Suture Craniosynostosis Phenotypes
Lapehn, S., Gustafson, J. A., Timms, A. E., Cunningham, M. L., & Paquette, A. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065353 · Cited by 3 · cited 1× · see citing works
“The majority of the studies studied the odds ratio of male occurring CS with an OR ranging from 1.46 to 4.5 (with geometric mean of ~ 2.7) [2, 3, 15, 26, 50, 53, 74, 80, 82, 86, 96–98, 102, 103, 117].”
InfluentialWalton, I. S., McCann, E., Weber, A. P., Morton, J. E. V., Noons, P., Wilson, L. C., Ching, R. C., Cilliers, D. D., Johnson, D., Phipps, J. M., et al. (2024) · Journal of Anatomy · doi:10.1111/joa.14052 · Cited by 2 · see citing works
Clinical-Epidemiological Study of a Cohort of 35 Patients with Craniosynostosis
SOMOLAN, C.-V., PETCHESI, C. D., JURCA, C., & BEMBEA, M. (2022) · Maedica - A Journal of Clinical Medicine · doi:10.26574/maedica.2022.17.4.893 · Cited by 2 · cited 2× · see citing works
“[103].”
InfluentialFisher, S. C., Romitti, P. A., Tracy, M., Howley, M. M., Jabs, E. W., Browne, M. L., & Study, T. N. B. D. P. (2024) · Birth Defects Research · doi:10.1002/bdr2.2420 · Cited by 2 · cited 1× · see citing works
“Maternal alcohol consumption has been associated with odds ratios close to unity (OR ~ 0.8–1.0) for sCS [56, 65], but this does not imply a protective effect and does not modify existing recommendations to abstain from alcohol during pregnancy.”
InfluentialYoon, J. G., Yu, J. W., Shim, K. W., Kim, Y. O., & Lee, M. G. (2024) · Clinical Genetics · doi:10.1111/cge.14539 · Cited by 1 · cited 1× · see citing works
“Additional convergence is seen in the Hedgehog pathway, involving ALX4 , IHH , and RAB23 [46, 72, 77], and in the RAS/MAPK cascade, given the association of sCS with RASopathies and variants in BRAF , PTPN11 , and MAP4K4 [61, 112, 122].”
Further delineation of the acro-renal-ocular syndrome
(1996) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-8628(19960329)62:3 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Cohen MM, MacLean RE (2000) Craniosynostosis: diagnosis, evaluation, and management, 2nd ed. Oxford University Press, New York
Cited by
Sorted by citations
Changing concepts in the genetics of craniosynostosis: A pediatric neurology perspective
Fonteles, C. S. R., Khuu, M. B., Bhavani, P., & Finnell, R. H. (2026) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2026.101330 · Cited by 1 · see citing works
- Authors
- De Gregorio, V., Tosi, D. D., Vita, A., Salvati, M., Massimi, L., Tamburrini, G., Tiberio, F., & Lattanzi, W.
- Affiliations
- Università Cattolica del Sacro Cuore (IT)
- Corresponding author
- Lattanzi, Wanda
- Venue
- Child's Nervous System
- Published
- 2026-07-18
- Volume
- 42
- Issue
- 1
- ISSN
- 0256-7040 (ISSN-L)
- 1433-0350
- PMC
- PMC13380559
- OpenAlex
- W7169685370
- Cited by
- 2
- References
- 122
- Citations by year
- 2026: 2
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Child s Nervous System (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- European Union—Next Generation EU—PNRR M6C2 (PNRR-POC-2023-12378222)
- AFM Telethon (Application Number: 29548)
- Università Cattolica del Sacro Cuore
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Craniofacial Disorders and Treatments
- Health Sciences › Medicine › Surgery › Pectus Deformity Diagnosis and Treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
- Keywords
- sagittal craniosynostosis, germline genetic variants, environmental risk factors, perinatal factors, multifactorial etiology, genetic susceptibility, maternal smoking, advanced maternal age, thyroid dysfunction, infertility treatment, preterm birth, pathogenesis
- MeSH terms
- Craniosynostoses, Environment, Female, Humans, Male, Genetic Predisposition to Disease, Gene-Environment Interaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review